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    INTRODUCTION 
Humans are the greatest of all organisms living in the world. It is not as easy to 
born as a human. Poet Auvaiyar puts it as follows: 
   “Human Birth Is Indeed A Rarity” 
 The ability to achieve self – realization is given to humans alone. The creative 
energy called God and the energy of inanimate things remain latent in humans. But not 
many of us either try to understand the hidden creative energy in us or use it properly. 
The object of human life is to realize the power in us and use it for the benefit if 
mankind. 
 Medicine is one of the greatest feats of mankind which brings health and 
happiness. It is very much important to note that the growth of medicine started based 
on the nature, the customs and the civilization of the respective peoples of the world. As 
the child called society grows along in the cradle called civilization, medicine has stood 
by nourishing and fostering the child. All systems of medicine are unique in their own 
ways. Medicine has evolved along with humans through changes and improvements in 
theory and practice. 
[1] 
 The Siddha System of Medicine is one of the ancient systems contemporaneous 
with those of the submerged lands, Egyptian, Mesopotamian, Chinese and Grecian 
medicines. The unique nature of this system is its continuous service to humanity for 
more than five thousand years in combating diseases and in maintaining its physical, 
mental and moral health, while many of its contemporaries had completed their courses 
long ago. 
[2] 
 The word “Siddha” not only denotes simplicity, uniqueness, ancientness, 
nobility, truth and purity but includes all these senses and stands a unique, lofty entity. 
“Siddhi” refers to a yogic state. “Siddhars” are said to be the yogis, having lived a 
complete life. 
[1-A]
 They were   revealed and offered the medicines to the world. 
They were well aware of the nature of illness and to save the patient and they 
contributed drugs to the world. Most of the Siddha medicines are prepared from the 
natural herbs and it has the power to demolish the disease cause, it is an effective 
curative dose with less toxicity. They gave the internal medicines in the form of 
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chooranam, kudineer, mathirai, vadagam, manapagu, legium, parpam, chendooram, 
chunnam, kattu, kalangu, etc.,  
 Siddha medicine is meant to be a “TREASURE MEDICINE” for multiple 
diseases to get cured.  
In Siddha, the term “Arthritis” is compared with “Keelvayu”. Keelvayu is a 
disease caused due to the derangement of Vadham or Vali humour mainly. It is 
classified into 10 different types. Of them, one of the commonest types is Vali Azhal 
Keelvayu, which can be compared to Rheumatoid Arthritis as per Modern medicine and 
it is caused due to derangement of Vali and Azhal humour.
  
Vali or Vatham is one of the three humors (Vali, Azhal, Iyam ) among five 
elements. Vali is formed by air and sky. In a healthy individual the existence of the 
three humours are in the ratio of 1:1/2:1/4 respectively. These are all the three pillars 
unite of functioning human body. When they de-arranged they are called Kuttram. 
Vatham is the most important humour because it regulates the equilibrium of the 
dearranged Kuttrams. In Vali Azhal Keelvayu (Rheumatoid Arthritis), Vali and azhal 
humours are affected. 
[3] 
Rheumatoid Arthritis (RA) is an inflammatory disease that causes pain, 
swelling, stiffness and loss of function in the joints. It occurs when the immune system, 
which normally defends the body from invading organisms, turns it attack against the 
membrane lining the joints.
 [4] 
It occurs in all races and ethnic groups. Although the 
disease often begins in middle age and occurs with increased frequency in older people, 
teenagers and young adults may also be diagnosed with the disease.
 
 Generally, a joint (the place where two bones meet) is surrounded by a capsule 
that protects and supports it. The joint capsule is lined with a type of tissue called 
synovium, which produces synovial fluid that lubricants and nourishes joint tissues. In 
rheumatoid arthritis, the synovium becomes inflamed causing warmth, redness, swelling 
and pain. As the disease progresses, the inflamed synovium invades and damages the 
cartilage and bone of the joint. Surrounding muscles, ligaments and tendons become 
weakened. It also can cause more generalised bone loss that may lead to Osteoporosis. 
(Fragile bones those are prone to fracture). 
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 RA affects people differently. Some people have mild or moderate forms of the 
disease with periods of worsening symptoms called flares and periods in which they feel 
better called remissions. Others have a severe form of the disease that is active most of 
the time last for many years or a lifetime and leads to serious joint damage and 
disability. Peoples are also experience issues related to depression, anxiety, feeling of 
helplessness and low self-esteem.
  
RA is the third most common type of arthritis behind Osteoarthritis (prevalence 
26.9 million). The incidence (new cases per year) of RA increases with increasing age 
in most populations until about the eighth decade of life when it declines. 
[5]  
The prevalence varies between 0.3% and 1%. It is more common in women and 
in developed countries. 
[6] 
Women are about two and half times more likely to get RA 
than men. Hormones in both genders may play a role in either preventing or triggering 
it. RA generally starts between the ages of 30 and 60 in women and somewhat later in 
life in men. The lifetime risk of developing RA is 4% for women and 3% for men. It 
can strike at any age even small children can get it. More than 3, 00,000 children have 
the juvenile form of the disease. 
[7] 
 In economic terms Rheumatoid Arthritis is a costly disease, both at personal and 
at a societal level. It is a condition which has a peak onset during middle age, therefore 
predominantly affecting individuals of working age. Approximately 75 % of new 
diagnosis of individuals who are working at the time of diagnosis. 
[8] 
 Rheumatoid awareness day to be held each year on February 2
nd 
giving people 
with the chronic illness known as rheumatoid arthritis or rheumatoid disease a day of 
recognition. Because the disease is commonly presumed to be a type of arthritis 
awareness is lacking.
 [9] 
 In 1981, World Health Organization (WHO) and International League 
Associations for Rheumatology (ILAR) launched a special program for rheumatoid 
diseases called COPCORD (Community Oriented Program for Control of Rheumatic 
Disease). 
[10] 
 The word “Rheumatology has its origin in the word “rheuma” which means 
flowing and it is mentioned in Hippocratic corpus. Hippocrates made several 
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observations about gout, popularly known as “aphorism of gout”. Many famous 
pointing in the medieval era depict joint disease. Hand lesions resembling those of RA 
are found in painting of the Flemish school. The famous portrait of Federigo de 
montefeltre, thought to have been painted by joos (Justus) van gent, shows arthritis of 
the proximal interphalangeal joint of the left index finger. 
[11] 
 Rheumatology developed as a well-recognized specialty of medicine in the 20
th
 
century. American physician Bernard Comroe and Joseph lee Hollender coined the term 
Rheumatology in 1949. Guillaume de baillou (1538-1616) a French physician 
introduced the term rheumatism who was the father of rheumatology. He tried to 
distinguish gout from other rheumatic disorders. 
 Rheumatoid arthritis is a challenge to the world of medicine, because it affects 
the patient mentally, physically, economically and his domestic life. It affects 1% of 
people in world population and the number of affected patients is also getting increased. 
The genetic factor HLA-DR4, HLA-DR1 plays important role. 
[12] 
   Many drugs are used for managing the pain and slowing the progression of 
Rheumatoid arthritis, but none completely cure the disease. The drug categories are 
used for RA include: Non – Steroidal Anti-inflammatory drugs (NSAIDs), Disease 
modifying anti rheumatic drugs(DMARDs), Biologic Response Modifiers (Biologic 
DMARDs), Anti TNF Drugs. 
NSAIDs are the least potent drugs used for RA. These drugs relieve pain by 
reducing inflammation. DMARDs are the main drugs used in the treatment of RA. They 
slow the progression of the disease. It is much more effective than NSAIDs but also 
have more side effects. All DMARDs may produce stomach and intestinal side effects 
and serious drug reactions.
 
NSAIDs produces adverse effects in GIT (Peptic ulcer, bowel ulceration/ 
perforation, colitis, stomatitis, oseophagitis), Renal diseases (Acute renal failure, 
interstitial nephritis, hyponatraemia, Hyperkalaemia, transient risk in serum creatinine), 
Cardiovascular (interference with actions of anti-hypertensive and anti-cardiac failure 
drugs), Hepatic failure, Cholestasis, CNS (Head ache, Insomnia, abnormal behaviour), 
skin rashes, erythema, bone marrow suppression and anaemia. The symptoms may 
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subside with administration of medicines but it may reoccur with more severity as the 
disease becomes chronic finally leading to permanent debility. 
[13] 
 Because of this condition patients suffer physically and mentally. So obviously 
they are in the period of expecting an alternative medicine. While in this situation, they 
are so many medicines are available in Siddha system of medicine which was all given 
by the Siddhars to help us to live a disease free life. 
 The people are in need to have easily available medicines to cure many diseases. 
Nature has given us a wide variety of medicine to preserve good health and cure 
diseases. The Siddha is dealing with natural system of medicines with minimal side 
effects. So Siddha system of medicine is a living science forever.  
There are many drugs are available in Siddha for the treatment of RA. The 
Author has chosen the compound drug “KEELVAYU NIVARANA CHOORANAM” 
which is going to be the best drug in the treatment of Rheumatoid Arthritis. And the 
present study is carried out to validate the Anti-Rheumatic potential through 
Standardization, Instrumental analysis, Toxicological profile and Pharmacological 
screening. 
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                                                     2. AIM AND OBJECTIVES 
 
AIM 
There is a need for valuable Anti Rheumatoid drugs in this present medical world. 
The aim of this study is to validate the analgesic, anti-inflammatory (acute and chronic) and 
anti-rheumatic activity of Keelvayu Nivarana Chooranam in animal model and also 
validate the safety profile of the trial drug through acute and repeated oral toxicity studies. 
 
OBJECTIVES 
The key objectives of the study are: 
  To collect various literature which include Siddha & Modern aspect of drug and 
disease review, pharmacological review and pharmaceutical review.   
  To prepare the trial drug according to Siddha classical literature. 
  To standardize the trial drug right through physico-chemical analysis. 
  To analyze the drug chemically for detection of acid, basic radicals and heavy 
  metals. 
  To assess the Acute and 28 days repeated oral toxicity profiles of Keelvayu 
 Nivarana Chooranam according to OECD guidelines. (OECD 423 and OECD 407) 
  To determine the Analgesic, Anti-inflammatory and Anti Rheumatic activity of 
Keelvayu Nivarana Chooranam. 
 
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
7 
3. REVIEW OF LITERATURE 
3.1. DRUG REVIEW 
    3.1.1. GUNAPADAM ASPECT 
     Nannari (Hemidesmus indicus) 
Synonyms     : Angarimooli, Pathalamooli, Kopagu, Saripam, Parrkodi, 
Neerundi, Kanannusari, Krishnavalli, Saariyam. 
Vernacular Names 
English  : Indian sarasaparilla 
Malayalam  : Nannari 
Kannada  : Sugandha - palada  
Telugu  : Sugandhi 
Sanskrit  : Sariba 
Hindi              : Magrabu 
Parts used : Root 
Taste  : Sweet, Mild bitter 
Character  : Coolant 
Division : Sweet 
Action  : Alternative 
  Tonic 
  Diuretic 
  Diaphoretic 
General Character  
“சயத ோடம் பித் ஫ ி ோகம் உறலய 
சயத஫று சீ ஫ின்னோர் ஞ்சு – டுயக஫ ிற் 
சசோன்ன஫து த஫கம் புண் சு஭஫ிலலச஬ யோச஫ோறிக்கும் 
ச஫ன்஫து஭ நன்னோரி தலர்.” 
- த ல஭஬ர் குணலோகடம்[14] 
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Indications 
Thirst, diabetes and anti-dote for insects bite. 
Medicinal uses 
 Root of Nannari therapeutically used in treatment used in treatment of Diabetes 
mellitus, Pittha disease, Tumour, Migraine, Arthritis, Indigestion. Also used in the 
treatment of urinary tract infection.
 [14-a] 
Parangipattai (Smilax chinensis) 
Synonyms :  Madhusmigam, Madhusmeegi, chinnapattai, Parangichakkai 
Vernacular Names 
English   : China root 
Malayalam   : Pavu 
Telugu  : Pirangi-chekka 
Sanskrit  : Madusnuhi 
Hindi   : Chobchini 
Parts used : Rhizome 
Taste  : Sweet 
Character  : Coolant 
Division :  Sweet 
Action  :  Alternative 
  Anti-syphilitic  
  Aphrodisiac 
  Depurative 
  Tonic 
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General Character 
“ ோகம் பயலோ ந் ோதுநட்டம் புண்பிரலல 
த஫கங் கடிகி஭ந் ி லழீ்மூயந்- த கமுடன் 
குட்லட பகந் த஫ற் சகோள்ல஫னம் தபோம்பமங்கிப் 
பட்லட஬ிலன ம௃ச்சரித்துப் போர்.”  
- த ல஭஬ர் குணலோகடம்[14-b] 
Indications 
Thirst, various Vadha diseases, diabetes, anti-dote for insects bite, scabies, piles,  
Medicinal uses 
Parangipattai decoction therapeutically used in the treatment of Vadha diseases, 
Eczema, Psoriasis, Pain, Diarrhoea, Abdominal distension, Leucorrhoea, Diabetes 
mellitus. 
                                             Amukkara (Withania somnifera)  
Synonyms     : Amukkiri, Amukkuravi, Amukkuravu, Amukkinangkizhangu, 
Ashwagandham, Ashwagandhi, Ashuvam, Irulichevi, Kidichevi,  
                              Varagakarni. 
Vernacular Names 
English      :  Winter cherry 
Malayalam     :  Amukkuram 
Kannada     :  Sogade-beru 
Telugu     :  Penneru- gadda 
Sanskrit     :  Aswagandha 
Urdu     :  Asgandh 
Parts used    : Leaves, Seeds, Rhizome 
Taste     :  Bitter 
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Character  :  Heat 
Division :  Pungent 
Action  :  Febrifuge 
   Diuretic 
   Sedative 
General Character 
―சகோஞ்சந் துலர்ப்போங் சகோடி஬க஬ம் சூலய஬ரி 
஫ிஞ்சுக஭ப் போன்போண்டு சலப்ப ப்பு- லிஞ்சி 
முசுவுறு த ோடமும்தபோ த஫ோகம்அன லுண்டோம் 
அசுலகந் ிக்சகன் மமி” 
- அகத் ி஬ர் குணலோகடம்[14-c] 
Indications 
Various Vadha diseases, Kapha diseases, fever, swelling. 
Medicinal uses 
Amukkara powder used as kayakarpam. It therapeutically used in treatment of 
Vadha diseases, Pain, Swelling, Obesity, Leucorrhoea, and Diabetes mellitus.  
Taking Amukkara chooranam with ghee increases the sperm count.   
 Chittraratthai (Alpinia officinarum) 
Synonyms :  Aratthai 
Vernacular Names 
English  :  Galangal the lesser, Java galangal 
Malayalam  :  Arattha 
Kannada  :  Rasmi 
Telugu  :  Sanna- rashtramu, Thumpa rashtramu 
Sanskrit  :  Rasna 
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Urdu   :  Khulanjan 
Parts used :  Root 
Taste  :  Pungent 
Character  :  Heat 
Division :  Pungent 
Action  :  Expectorant 
   Ferbrifuge 
  Alternative 
General Character 
“லோ பித் ங்க஭ப்போன் லோ ஞ் சித஭ோத஭ோகஞ் 
தசர்ந் கப முத்த ோடஞ் சீ ச஫ோடு- தநர்ந் சு஭ம் 
஫ற்ம஭த்ல க் கோட்டி லரு஫ிரு஫ லுந் ீரும் 
சிற்மத்ல  லன்஫ருந் ோய் த ர் .” 
- த ல஭஬ர் குணலோகடம்[14-d] 
Indications  
Kapha Diseases (Cough with expectoration, Tuberculosis), Eczema, Chest pain, 
Swelling, Dental Disease.  
Medicinal uses 
On chewing a small piece of Chittraraththai cures vomiting and coughs with 
expectoration. Root of Chirraraththai therapeutically used in treatment of Vadha 
diseases, cold, fever, vomiting, head ache. 
Decoction of Chittraraththai cures fever, cough, pain, swelling, head ache. 
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3.1.2. BOTANICAL ASPECT  
    Hemidesmus  indicus 
Taxonomical classification 
Kingdom  :  Plantae 
Division :  Magnoliophyta 
Class  : Magnoliopsida  
Order  :  Gentianales                                                  
Family  :  Apocynaceae  
Genus  :  Hemidesmus 
Species :  indicus 
Distribution 
 Throughout India 
Description  
A perennial, slender, lacticiferous, twining or prostate, wiry shrub, with woody 
root, stock and numerous, slender, terete, stems having thickend nodes, leaves simple, 
opposite, very variable from elliptic-oblong to linear lanceolate, variegated with white 
above, silvery white and pubescent beneath, flower greenish purple crowed in subsessile 
cymes in the opposite leaf axils; fruits slender follicles, cylindrical, 10cm long, tapering 
to a point, at the apex, seeds flattenend, black, ovate, oblong, coma silvery white.  
The tuberous root is dark- brown, coma silvery white, tortuous with transversely 
cracked and longitudinally fissured bark. It has a strong central vasculature and a 
pleasant smell and taste.
 [15] 
Anatomy 
            Transverse section of the fresh root is circular with a fairly regular outline. It 
shows a slightly compact porous strand of wood at the centre enveloped by a massive 
cream coloured starchy tissue and a peripheral strip of light reddish brown rind. 
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Parts used 
Roots, Leaves, Stem. 
Chemical constituents 
Different parts of the plant especially root contain various compounds such as 2-
hydroxy 4-methoxy benzaldehyde, 4-hydroxy 3-methoxy benzaldehyde, lupeol, ledol, 
nerolidol, linalyl acetate, dihydrocarvyl acetate, cis-caryophyllene, isocaryophyllene, β-
selinene, dodecanoic acid, hexadecanoic acid, camphor, borneol, dehydrolupanyl-3 
acetate, dehydrolupeol acetate, 3-hydroxy 4-methoxy benzaldehyde, hexadecanoic acid, 
hexatriacontane, lupeol octacosanoate, β-amyrin acetate, lupeol acetate, α-amyrin, β-
amyrin, sitosterol, drevogenin β-3-O-β-D-oleandropyranosyl, hemidesmin-1, 
hemidesmin-2, hemidesminine, phytosterols, triterpenes, saponin, resin acid, tannins, 
tetracyclic triterpene alcohols, fatty acids, glycosides, 16-dehydropregnenolone, a new 
pregnane ester diglycoside (desinine), indicine, hemidine and rutin are the chief 
components present in the plant.
[16] 
Properties and uses 
 The roots are bitter, sweet, astringent, aromatic, refrigerant, emollient, 
depurative, aphrodisiac, carminative, appetizer, anthelmintic, alterant, demulcent, 
diaphoretic, febrifuge, experctorant and tonic. 
 They are useful in vitiated conditions of pittha, burning sensations, leucoderma, 
leprosy, skin diseases, pruritis, asthma, bronchitis, hyperdipsia, opthalmopathy, 
emicranians, epileptic fits, dyspepsia, helminthiasis, dysentery, haemorrhoids, 
strangury, leucorrhoa, syphilis, abscess,arthralgia, fever and general debility. 
 The leaves are useful in vomiting, wounds and leucoderma. 
 The stems are bitter, diaphoretic, laxative and are useful in inflammations, 
cerebropathy, nephropathy, syphilis, leucoderma, odontalgia, cough, asthma.  
The latex is good for conjunctivitis.
 [15] 
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Smilax chinensis 
Taxonomical classification 
Kingdom  :  Plantae          
Division :  Tracheophyta    
Class  :  Magnoliopsida 
Order  :  Liliales 
Family  :  Liliaceae 
Genus  :  Smilax 
Species :  chinensis 
Distribution 
  In China and Japan 
Description 
 A hard tendril climber with sparsely prickled or unarmed stems and thick 
tuberous rhizomes. 
Leaves simple, alternate, elliotic, rounded at the base, prominently nerved. 
Flowers many, small, white inumbels. 
Fruits red berries.
  
Parts used 
 Rhizomes 
Chemical constituents 
Thirteen compounds were obtained and identified as kaemperol-7-O-beta-D-
glucopyranoside, engeletin, isoengeletin, kaempferol, dihydrokaempferol, 
dihydrokaempferol-5-O-P-D-glucopyranoside, rutin, kaempferol- 5-O-beta-D-
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glucopyranoside, 3, 5, 4'-trihydroxystibene, vanillic acid, 3, 5-dimethoxy4-O-beta-D-
glu-copyranosylcinnamic acid, beta-sitosterol, and beta-daucosterol, respectively.
[18] 
Properties and uses 
 The rhizomes are bitter, acrid, thermogenic, anodyne, anti-inflammatory, 
digestive, laxative, depurative, aphrodisiac, diuretic, sudorific, febrifuge and tonic.  
 They are useful in syphilis, leprosy, skin diseases, epilepsy, insanity, scrofula, 
vitiated conditions of vadha, flatulence, dyspepsia, colic, neuralgia, constipation, 
helminthiasis, psoriasis, fever, strangury, seminal weakness and general debility.
 [17] 
Withania somnifera 
Taxonomical classification                                      
 Kingdom  :  Plantae 
Division :  Tracheophyta  
Class  :  Magnoliopsida 
Order  :  Solanales 
Family  :  Solanaceae 
Genus  :  Withania 
Species :  somnifera 
Distribution   : Throughout the drier parts of India, in waste places also. 
External Morphology
[18] 
Plant 
The plant is an erect, perennial, much branched undershrub growing to1-3m in 
height 
Stem 
It is terate, branched, cylindrical, solid, clothed with mealy, stellate-
hoarytomentun, at length somewhat glabrous  
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Root  
Roots straight, unbranched, thickness varying with age, roots bear fibre like 
secondary roots, outer surface buff to gray yellow with longitudinal wrinkles;crown 
consists of 2-6 remains of stem base; stem bases variously thickened;nodes prominent 
only on the side from where petiole arises, cylindrical, greenwith longitudinal wrinkles; 
fracture, short and uneven; odour, characteristic;bitter and acrid. The roots when dry are 
cylindrical, gradually tapering down with a brownish white surface and pure white 
inside when broken  
Leaves  
Leaves are cauline and ramal, simple, exstipulate, petiolate, ovate, acute, 
entire,and up to 10 cm long. Petioles up to 1.25 cm long. The leaves on vegetative 
shoots are alternate and large while those on floral branches are opposite,rounded or 
somewhat produced at base, pubescent on lower surface and glabrous on upper surface 
unicostate, reticulate venation. Arranged in pairs of one large and one small leaf and 
arranged somewhat laterally, having in their axila cymose cluster of 5-25 inconspicuous 
pale green flowers. 
Inflorescence  
It is solitary, axillary  
Flowers 
Flowers are ebracteate, pedicellate, complete, hermaphrodite, pentamerous, 
actinomorphic and hypogynous, gamosepalous, 4-6 mm in diameter,  lucid-yellow or 
greenish. 
Calyx 
Sepals are five, fused, tubular,persistent, green, hairy. 
Corolla  
Petals are five, united, tubular, gamopetalous, lobes spreading or recurved, 
acute,pubescent and greenish yellow. Aestivation is valvate or imbricate. 
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Androecium 
Stamens are five, attached near the base of the corolla,  epipetalous, anthers 
oblong, dehiscing longitudinally, introrse, dithecous, filament deeply inserted in corolla 
tube ,linear slender  
Gynoecium 
 It is bicarpellary, syncarpous, composedof minute swollen ovary, ovary 
superior, placed obliquely, placentation axile,with many ovules in each locule, style 
simple, stigma shortly bifid 
Flowering time 
Winter 
Fruits 
 Fruitis a berry enclosed in the green persistent calyx, 5 mm in diameter, 
smooth,more or less globose, green when unripe, orange-red coloured in ripening stage 
Seeds 
 Bean shaped, endospermic, yellow andorange-red coloured, somewhat scurfy. 
Fruit contains numerous small Capsicum like seeds . 
Pollination 
Entomorphilous. 
Parts used  
Roots and Leaves.
 [19] 
Chemical constituents 
Alkaloids: Withanine, Withaninine, Somniferine, Tropeltigloate, Somniferinine, 
Somninine, Nicotine, Visamine, Withasomine  
Salts: Cuscohygrine, Anahygrine, Tropine, Pseudotropine, Anaferine 
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 Steroidal Lactones: Withaferin-A, Withanone, WS-1, Withanolide E 
C28H38O7, Withanolide F C28H38O6, Withanolide G C28H36O4, Withanolide H 
C28H36O5, Withanolide I C28H36O5, Withanolide J C28H36O5, Withanolide K 
C28H36O5, Withanolide L C28H36O5, Withanolide M  
Nitrogen containing compounds: Withanol C25H34O5, Somnisol C32H46O, 
Somnitol C33H46O7  
Steroids:Cholesterol, -sitosterol, Stigmasterol, Diosgenin, Stigmastadien, 
Sitoinosides VII, Sitoinosides VIII, Sitoinosides IX, Sitoinosides X  
Flavonoids: Kaempferol, Quercetin.
[20] 
Uses 
  The tuberous roots are astringent, bitter, acrid, somniferous, thermogenic, 
stimulant, aphrodisiac, diuretic and tonic. 
 They are useful in vitiated conditions of vadha, leucoderma, constipation, 
insomnia, tissue building and nervous breakdown. 
 The leaves are bitter and are recommended in fever, painful swellings and 
opthalmitis. 
 A paste of the roots and bruised leaves are applied to carbuncles, ulcers and 
painful swellings.
 [19] 
Medicinal uses 
 Ashwagangha is a revitalizing herb that maintains proper nourishment of 
tisuues, particularly muscle and bones. 
 It increases resistance to stress and mainly beneficial in stress related 
disorders such as arthritis, hypertension, tremors, diabetes, general 
debility and inflammation. It increases body's resistance towards adverse 
influence. 
 It restores the neurotransmitters and hence useful in various mental 
disorders. 
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 It is also used for treating memory loss. 
 It supports proper function of adrenals and reproductive system. 
 As it is powerful aphrodisiac, it is also used for sexual vitality and as an 
adaptogen. 
 It is blood tonifier, that improves circulation and absorption of nutrients 
from the cells 
Medicinal properties 
 It has anti-stress, adaptogenic, aphrodisiac, sedative, diuretic, 
antispasmodic, germicidal, anti-inflammatory action. 
 It is a nervine tonic. 
 It enhances immunity and endurance. 
 It is  a natural nutrient for insomnia 
 It is good hypnotic in Alcoholism. 
 It is bitter in taste and hot in potency so it alleviates vata and kapha. 
 It stimulates thyroid activity. 
 Enhances anti-peroxidation of liver 
Alpinia officinarum 
Taxonomical classification 
Kingdom  :  Plantae     
Division :  Tracheophyta 
Class  :  Magnoliopsida 
Order  :  Zingiberales 
Family  :  Zingiberaceae 
Genus  :  Alpinia 
Species :  officinarum 
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Distribution     
Alpinia officinarum Hance (Zingiberaceae), commonly known as lesser 
galangal, is an important plant from the ginger family that originates in southern China 
and is cultivated in Southeast Asia.
 [21] 
Description  
 The branched pieces of rhizome are from 1 1/2 to 3 inches in length, and seldom 
more than 3/4 inch thick. They are cut while fresh, and the pieces are usually 
cylindrical, marked at short intervals by narrow, whitish, somewhat raised rings, which 
are the scars left by former leaves.  
They are dark reddish-brown externally, and the section shows a dark centre 
surrounded by a wider, paler layer which becomes darker in drying. 
[15-a] 
Microscopic studies 
 
T.S of rhizome  
Under a microscope, transverse section reveals epidermal cells often containing 
resin-like substances; cortex, endodermis and stele present beneath the epidermis; 
cortex and stele divided by endodermis; vascular bundles surrounded by fibers, 
scattered throughout the cortex and stele, cortex and stele composed of parenchyma 
interspersed with oil cells; parenchymatous cells containing solitary crystals of calcium 
oxalate and starch grains, starch grains generally simple (sometimes 2 to 8 compound), 
ovate, oblong or narrowly ovate, 10 to 40 mm in diameter and with an eccentric navel. 
Powder microscopy  
Powdered microscopy revealed the presence of parenchymatous cells in surface 
view with fragments of epidermal cells. Fragments of vessels having scalariform 
thickening are presents. Many circular starch grains are presents. 
Parts used 
Roots 
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Chemical constituents 
Four crystalline substances were isolated from rhizome of Alpinia officinarum 
Hance. They were identified as beta-Sitosterol (I), Galangin (II), Emodin (III) and 
Quercetin (IV), I and III.
 [22] 
Properties and uses 
 The rhizomes are bitter, acrid, nervine tonic, carminative, expectorant, anti-
inflammatory and tonic. They are useful in vitiated conditions of Vadha and Kapha, 
Rheumatoid Arthritis, Inflammations, Cough, Asthma, Bronchitis, Dyspepsia And 
Intermittent Fevers.
[15-a]
 
3.2. DISEASE REVIEW 
                           3.2.1. SIDDHA ASPECT- VALIAZHAL KEELVAYU 
Other names 
[23] 
 Mudakku vayu, Sandhu vadham, Mootu vali, Maega soolai, Aama vadham. 
“லரிம௃ ல஫ம௃ந் ன்னிலய சகட்டு 
லரிம௃டன் லகீ்கச் சு஭மும் கோய்ந்து 
  மூட்டுக தடோறும் முடுக்கித஬ சநோந்து 
மூட்டுக டன்னின் நீரும் சு஭ந்து 
   ோங்சகோணோ லயிம௃டன் சநோந் ிடு ஫ம்த஫” 
       (சபோப ி லகத஬டு) 
Types 
 Valikeelvayu 
 Theekkeelvayu 
 Iyakeelvayu 
 Valitheekkeelvayu 
 Valiiyakkeelvayu 
 Theevalikeelvayu 
 Theeiyakkeelvayu 
 Iyavalikeelvayu 
 Iyatheekkeelvayu 
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 Mukkuttrakeelvayu  
 
Valitheekkeelvayu (வளித்தகீ்கீல்வாயு) 
                                  “லோ பித் க்கில் லோய்லின் 
                                                  லருங்குமி சோற்மிக் தகரோய் 
                                          ஏ ஫ோர் ஫ந்  த஫ப்பம்   
                                                  இல஭ச்சலும் ல஬ிற்மிற் கோணும் 
                                         ஓ ருங் குத் ல் லகீ்கம்  
                                                  ஓய் யில் எரிச்ச லுண்டோம் 
                                      கோ று முமக்க ஫ின்ல஫ 
                                                   கோய்ச்சலும் கோணுங் கண்டோய்” 
 
Symptoms 
 Elevation of Vadha and Pittha kuttram causes swelling in the wrist 
joint, ankle joints ( including all major and minor joints). 
 Reddness  
 Pain  
 Fever  
 Insomnia 
According to Siddha text causes for Vadha diseases 
        ―தநோ஬ினுற் பத் ிதகள் தநோன்ல஫ கூர்ல஫ந் தன 
        தநோ஬ோரி ச஬ன்ப று தநோ஬ோரி முன்தன 
         தநோய்கள் லிலன கோ ஭மு தநோய்கள் ல஭தலது 
         தநோனோல஫ ஬ோல்தலகுரி தநோனோ  பசி஬ோல் 
       தநோனோ  நீர்பருகல் தநோனோ  உணலோல் 
தநோக்க஫ரு ணம் ோக தநோக்கிச஬ோறி ச ோறி யோல் 
       தநோக்கச஭ன நட஫ோடி தநோக்கி நட஫ிடயோல் 
       தநோட்டக்கோ ஭ரிநோடி தநோட்டச஫ோறி கு஭யோல் 
      தநோல஬ர் ஫ோ த஭ோடு தநோல ஫ருவு யோல் 
       தநோன்புலி஭ ோ ிபய தநோற்கலரு ச஫யிலோல் 
           தநோஞ்லசச஬ன லணுகுணவு தநோல ல஬ிலு யோல் 
           தநோனோ  ல஭ீ஫டி தநோனலணி கு யோல் 
            தநோய்களுற் பத் ிலழு தநோய்கள் லிலனலில ஬ோய் 
          தநோய்கள் லிலன ல஬யோய் ச஫ய்தநோய்கள் லரர்ப஬ி஭ோய் 
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             தநோம௃ வு பயனோகி தநோய்கள் சலகுத஫யோம் 
          தநோ க உல஭த் ண஫ிந் தநோய்கரம த஫தய” 
- த ஭ன் கரிசல் 
-  
“ க்கலோம௃ தகோபித் ோல் சந்து அலரந்து லயதநோலோம் 
  ஫ிக்கமுர் சகோட்டோலி லிட்டது சகரி஬ ஫யங்கட்டும் 
  ஒக்கந஭ம்பு ோன் முடங்கு மூய஫ந்து லோய் நீருமிலரும் 
  ஫ிக்கு குரிரும் நடுக்க஫ோம் த஫னிகுன்மி லருங்கோதண” 
- த ல஭஬ர் லோகடம் 
Theraiyar vagadam discusses that the vitiated conditions of vali as follows: 
 Pain in the joints 
 Head ache 
 Excessive yawning 
 Burning sensation of the body 
 Constipation 
 Chillness  
 Rigor 
Symptoms 
      “அமி஬ இம்மூன்மின் ன்ல஫ சசோன்னோர் என நந் ி 
      எரி அனல் லோ ம் எரிக்கும் குணம் தகளு 
      குமி எனக் லககோல் குலரச்சு லியோச் சந்து 
     பமி என சநோந்துடல் பச்லச புண் ஆகுத஫ 
      புண்ணோய், லயிக்கும் சபோருமும் குடல் ஓடித் 
       ண்ணோ ஫யம் அ லனத் ம்பிக்கும் தபோக்கோது 
      ஒண்ணோ அசனம் உமதல கருக்கிடும் 
     பன்னோர் குரிர்- சீ ம் பகுத் ிடும் லோ த஫” 
                                          - ிருமூயர் ிரு஫ந் ி஭ம். 
 Pain in the metacarpal and metatarsal joints 
 Pain in the intercostal area 
 Pain all over the body 
 Dyspepsia 
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
24 
 Constipation 
 Loss of appetite 
In Siddha system treatment for Rheumatoid Arthritis 
Internal medicine 
Chooranam 
 Amukkara Chooranam 
 Parangipattai Chooranam 
 Thirikaduku Chooranam 
Parpam 
 Sangu Parpam 
 Velli Parpam 
 Palagarai Parpam 
 Thanga Parpam 
 Pavazha Parpam 
 Muttaiottu Parpam 
Chendhooram 
 Ayaveera Chendhooram 
 Arumuga Chendhooram 
 Chandamarutha Chendhooram 
 Kaalamega Narayana Chendhooram 
 Poorana Chandhrothayam 
 Thanga Chendhooram 
Chunnam 
 Velvanga Chunnam 
 Rasa Chunnam 
Mezhugu 
 Veera Mezhugu 
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 Nandhi Mezhugu 
 Rasagandhi Mezhugu 
 Vaan Mezhugu 
External Medicines 
Pattru 
 Moosambara Pattru 
 Kazharchi Pattru 
 Kaavikkal Pattru 
Thylam  
 Vadhakesari Thylam 
 Etti Thylam 
 Kukil Thylam 
 Sadamaanjil Thylam 
 Ulunthu Thylam 
 Meruguli Thylam 
 Mezhugu Thylam 
                     3.2.2. MODERN ASPECTS – RHEUMATOID ARTHRITIS 
Definition 
 Rheumatoid arthritis is a chronic systemic inflammatory disease of joints 
characterized by symmetrical relapsing ankylosing polyarthritis affecting mainly the 
peripheral small joints initially, associated with varied constitutional symptoms and 
presence of Rheumatic factor.
 [24] 
It affects the lining of joints, causing a painful swelling that can eventually result 
in bone erosion and joint deformity. 
An auto immune disorder rheumatoid arthritis occurs when immune system 
mistakenly attacks own body‘s tissue. In addition to causing joint problems, rheumatoid 
arthritis sometimes can affect other organs of the body such as the skin, eyes, lungs and 
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blood vessels. RA can occur at any age, it usually begins after age 40. The disorder is 
much more common in women. 
   Rheumatoid arthritis is a disease affecting the connective tissue of the whole 
body with focalized involvement of the musculoskeletal system.
 [25]
  
According to modern medicine Rheumatoid arthritis is a disease with genetically 
susceptible. Rheuma means fluid; it affects the synovial fluid of the joints. RA is a 
chronic auto immune disease with inflammation of joints and marked deformities, 
something triggers an attack on the synovium by the immune system which release 
cytokines that stimulates the inflammatory reaction that can lead to the destruction of all 
components of the joints.   It affects 1% of people in world population. The genetic 
factor HLA-DRB 4 plays an important role in this disease. The human leukocyte 
antigen system is the locus of genes that encode for proteins and surface of cell that are 
responsible for immune system in human, any alteration in this system caused several 
disease. Auto immune diseases also caused by alteration in these Human leukocytes 
antigen systems.
 [26] 
Aetiology 
                        RA is an autoimmune disease. Concordance rates are higher in 
monozygotic twins (12-15%) than in dizygotic twins (3%) and frequency of disease is 
increased in first degree relatives of patients with RA. Up to 50% of the genetic 
contribution to susceptibility is due to genes in the HLA region. HLA-DR4 is the major 
susceptibility haplotype in most ethnic groups, occurring, for example, in 50-75% of 
Caucasian patients with RA compared to 20-25% of the normal population. However, 
DRI is more important in Indians and Israelis and DW15 in Japanese. It is likely that 
genetic factors influence both susceptibility and severity, with DR4 positivity more 
common in those with severe erosive disease. 
                        Female gender is a risk factor and this susceptibility is increased post-
partum and by breast feeding. No infectious agents have been consistently isolated and 
there is no evidence of disease clustering. Cigarette smoking is a risk factor for RA and 
for positivity for rheumatoid factor in non-RA subjects.
 [27] 
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
27 
Although the cause of rheumatoid arthritis remains obscure, there is increasing 
evidence that the disease is triggered by T- lymphocytes in genetically predisposed 
individuals with define HLA class II haplotypes.HLA-DR4 is the major susceptibility 
haplotype in most ethnic group but DR1 is more important in Indians.HLA-DR4  sub 
types results from only few amino acid difference in the third hyper variable region of 
the amino acid sequence a though several other HLA allies that have more recently been 
associated with RA in some population.
[28]
  
Pathology 
                       RA is characterized by persistent cellular activation, autoimmunity and 
the presence of immune complexes at sites of articular and extra-articular lesions. This 
leads to chronic inflammation, granuloma formation and joint destruction. The earliest 
change is swelling and congestion of the synovial membrane and the underlying 
connective tissues, which become infiltrated with lymphocytes (especially CD4 T cells), 
plasma cells and macrophages. Effusion of synovial fluid into the joint space takes 
place during active phases of the disease. Hypertrophy of the synovial membrane 
occurs, with the formation of lymphoid follicles resembling an immunologically active 
lymph node. Inflammatory granulation tissue (pannus) spreads over and under the 
articular cartilage, which is progressively eroded and destroyed. Later, fibrous or bony 
ankylosis may occur. Muscles adjacent to inflamed joints atrophy and there may be 
focal infiltration with lymphocytes. 
                      Subcutaneous nodules consist of a central area of fibrinoid material 
surrounded by a palisade of proliferating mononuclear cells. Similar granulomatous 
lesions may occur in the pleura, lung, pericardium and sclera. Lymph nodes are often 
hyperplastic, showing many lymphoid follicles with large germinal centres and 
numerous plasma cells in the sinuses and medullary cords. Immunofluorescence 
confirms ‗Rheumatoid factor‘ autoantibody synthesis by plasma cells in synovium and 
lymph nodes. 
        The earliest findings include micro vascular injury and proliferation of synovial 
cells accompanied by interstitial oedema and perivascular infiltration.
 [29] 
        In synovial fluid, immune complexes activate the complement system. Kinins, 
phagocytic cells and the release of lysosomal enzyme and oxygen free radicals. 
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Mediators produced in this process stimulate synovial cells to proliferate and to 
produce proteinases and prostaglandins. These products cause dissolution of the 
connective tissue macromolecules as well as articular cartilage.
 [30] 
The ultimate destruction of cartilage, bone, tendons and ligaments probably 
result from a variety of proteolytic enzymes, metalloproteinases and soluble mediators. 
Collaginase, produced at the interface of pannus and cartilage is proably largely 
responsible for the typical erosions.  
 Criteria for diagnosis of Rheumatoid arthritis 
[26-a] 
                         Diagnosis of RA is made with four or more of the following, 
1. Morning stiffness (>1 hour) 
2. Arthritis of three or more joint areas 
3. Arthritis of hand joints 
4. Symmetrical arthritis 
5. Rheumatoid nodules 
6. Rheumatoid factor 
7. Radiological changes 
8. Duration of 6 weeks or more. 
       Predisposing causes:
[24-a]
 
 Heredity : It may play a part in 5% to 10% of cases 
 Trauma :  In many cases history of trauma is present 
 Climate : It was thought to be more common in temperate climates. However, it 
is equally prevalent in India also. 
 Psychic factors: Psychic upsets may aggravate the disease. 
 Infections :Existence of an infetcious agent Mycoplasma Epstein barr virus, 
Cyto Megalo virus or rubella virus either local/ systemic prior to attack of RA. 
Inflammatory fluid contains lymphocytes plasma cells and some macrophages at 
places forming lymphoid follicles. These is foci fibroid necrosis and fibrin 
deposition. 
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 Inflammation: Inflammation of synovial membrane oedematous thick with 
inflammatory exudation. It follows 3 stage synovitis, destruction and deformity. 
Microscopy shows lymphoid follicles forming nodules with scattered cells. 
Clinical features
 [31] 
 Age: Common in adults and middle aged subjects (20-40 years). 
 Sex: Common in females (3:1) 
 Morning stiffness 
 Involves small joints of hands and feet later spread to proximal joint like 
knee, hips, elbow and shoulder 
 Occasionally mono articular joint affected 
 Inflammation –spindle shaped 
 Joint line tenderness and movements are painful and limited 
 There is effusion in to the joint 
 Synovium becomes thick and tender 
 If presence of knee joint swelling its look like fusiform shape with 
pericapsular swelling 
 Tennis elbow present 
Extra articular manifestation 
Skin: Subcutaneous nodules, palmar erythema and fragility of the skin. Rheumatoid 
vaculitis. 
Neurologic manifestation
 [32] 
   Peripheral neuropathy produced by proliferating synovium causing compression 
of nerves carpal tunnel syndrome, tarsal tunnel syndrome offer associated with wrist or 
foot drop. 
Ophthalmic manifestation 
[33] 
  Siogrens syndrome cause corneal damage associated with dryness of the eyes. 
Scleritis may result in visual impairment. 
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Felty’s syndrome [34] 
Triad of chronic rheumatoid arthritis, splenomegaly and neutropenia is 
associated with lymphadenopathy  
Causes of RA 
[35] 
Rheumatoid arthritis occurs when immune system attacks the synovium which is 
the lining of the membrane that surround joints. 
The resulting inflammation thickens the synovium, which can eventually destroy 
the cartilage and bone within the joint 
The tendons and ligaments that hold the join together weaken and stretch. 
Gradually the joint loses its shapes and alignment. 
Genetic component actually causes rheumatoid arthritis .they can make more 
susceptible to environmental factors, such as infection with certain viruses and bacteria 
that may trigger the disease. 
[36]
    
Symptoms of RA 
 Swelling, warm and stiffness around the affected joints  
 Loss of appetite that results in weight loss 
 Fever and fatigueness  
 Continuity of stiffness in the morning for around 1-2 hrs 
 Firm bumps of tissue under the skin on arm (rheumatoid nodules) 
Early RA tends to affect the small joint first particularly the joints that attach 
fingers to hands toes and feet. As the disease progresses symptoms often spread to the 
wrists, knee ankles elbows, hips and shoulders in more cases symptoms occurs in the 
same joints on both sides of the body. 
Signs and symptoms may vary in severity and may even come and go .periods of 
increased disease activity, called flases, alternate with periods of relative remission, 
when the swelling and pain fade or disappear. Over time, RA can cause joints to deform 
and shift out of place 
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Onset 
             Insidious             -70% 
            Oligo articular     - 44% 
            Poly articular      - 35% 
            Mono articular     - 21% 
            Acute                   - 15% 
            Systemic              - 10% 
            Palindromic         -   5%  
Insidious 
The majority of RA develops insidiously over weeks or months with gradually 
increasing joint involvement. 
Poly articular onset 
This onset is very rapid, even over night with severe symmrtrical poly articular 
involvement. 
Mono articular onset 
  In young women initially very limited joint involvement particularly involving 
the knee. 
Systemic onset 
Common middle aged women, Non-articular features may dominate the clinical 
picture, fever, Myalgia, Weight loss, anaemia, pleural effusion, vasculitis lesion may be 
severe 
Palindric onset 
Patient with RA persistent joint disease may be antedated by repeated attacks of 
acute self- limiting synovitis affecting variable number of joints.    
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Risk factors 
Factors that may increase risk of rheumatoid arthritis include 
Sex: women are more likely to develop rheumatoid arthritis 
Age: rheumatoid arthritis can occur at any age but it most commonly 
begins between the age of 40 and 60 
Familial history: If a member of family has rheumatoid arthritis, it may 
have an increased risk of the disease 
Rheumatoid nodules 
Rheumatoid nodules are the most common dermatologic manifestation of 
Rheumatoid arthritis (RA), occurring in approximately one-fourth of RA patients. 
Similar to other autoimmune diseases, RA affects women three times as often as men. 
Antibodies created by the immune system against one's own cells cause inflammation 
and pain in the synovial lining of joints and other tissues. The results of this 
inflammation include morning stiffness, joint destruction, symmetric multi-joint 
arthritis and sometimes lung, heart or other organ complications. Severity of this disease 
is wide ranging from mild discomfort to complete debilitation and the presence of 
nodules may signify a more severe and destructive form of RA. 
Rheumatoid nodules are well-demarcated; flesh colored, subcutaneous lumps or 
masses which are usually freely movable, though attachment to underlying tissues is 
possible. The nodules can vary in size from small, pea sized lesions up to the size of a 
lemon. RA nodules are most often round though sometimes taking a linear shape. To 
the touch, nodules may feel doughy or firm however are usually not tender unless there 
is inflammation, ulceration or impingement of underlying structures such as nerves. 
Typically rheumatoid nodules are distributed over areas of repeated trauma or pressure 
and occur adjacent to joints on extensor surfaces, such as the elbow, fingers and 
forearms. In patients who are bedridden, areas of prolonged pressure such as the heel, 
Achilles tendon, posterior scalp, hip and sacrum are often affected. 
 Rheumatoid nodules may also occur internally, in sites unassociated with joints, 
such as in the sclera of the eyes, lungs or vocal cords, however diagnosis in those 
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locations is difficult. In patients treating their RA with methotrexate (an immune 
modulating drug), accelerated formation and growth of rheumatoid nodules, most 
commonly in the joints of the hands, may occur. This is known as accelerated nodulosis. 
Discontinuation of methotrexate or the addition of another medication may reverse or 
shrink nodules due to methotrexate therapy, though collaboration with the patient‘s 
rheumatologist is important before any medication changes. Interestingly, rheumatoid 
nodules occur almost exclusively in seropositive patients, meaning patients who are 
positive for a marker of RA known as Rheumatoid Factor (RF). 
Diagnosis of rheumatoid nodules can typically be made based on a positive 
history of RA and thorough physical exam demonstrating asymptomatic, slow growing, 
moveable subcutaneous nodules on extensor surfaces. This is especially true when the 
patient's rheumatoid factor titer is high. In most patients, the arthritis symptoms precede 
the development of rheumatoid nodules, however in a small percentage; nodules are 
present on initial diagnosis. Biopsy of mature lesions, though often not necessary, show 
a very typical histological appearance of central necrosis surrounded by palisading 
histiocytes and macrophages with an outer layer of fibroblasts, lymphocytes and plasma 
cells owing to the rich vascular supply. 
Of note, other immune-mediated diseases, such as systemic lupus erythematosus 
or ankylosing spondylitis, may produce lesions with a very similar histological 
appearance. Additionally, in young healthy children, a similar benign often self-
resolving dermatologic entity occurs known as subcutaneous granuloma annulare or 
pseudorheumatoid nodules. The differential diagnosis for subcutaneous nodules is 
extensive and includes fibromas, tophi (gout or pseudogout), metastatic lesions, 
xanthomas, epidermoid cysts, subcutaneous granuloma annulare, basal cell carcinoma 
and a variety of other lesions. 
Treatment of rheumatoid nodules is not always necessary, especially when they 
are mostly a cosmetic concern. Symptomatic lesions however, such as those infected, 
ulcerated, impinging of underlying nerves, or causing dysfunction due to location (e.g. 
the bottom of the foot), deserve more aggressive therapy. This is particularly true if a 
patient is on immunosuppressive medications for their RA. Injection with 
corticosteroids such as methylprednisolone is one treatment option that is usually 
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successful in decreasing the size of the nodules; however increased risk of infection or 
ulceration occurs with any type of injection. If lesions are already ulcerated, infected, 
entrapping peripheral nerves, limiting range of motion or in a location that incurs 
repeated trauma, then surgical excision is indicated. Unfortunately, nodules often recur 
at sites of excision. Patients should talk with their physician and decide the best course 
of action in each individual case. Though rheumatoid nodules typically are benign in 
nature, negative psychological effects due to the physical limitation and deformity are 
not uncommon. Patients should collaborate with their physician to receive treatment 
appropriate for their physical and psychological needs. 
Complications
 
 Joint destruction and deformity: In rheumatoid arthritis, the body's immune 
system attacks the joint lining (synovium), leading to cartilage and bone 
damage. If untreated, chronic joint inflammation can lead to permanent joint 
damage and deformity. The best way to prevent deformities of the hands, 
fingers, feet, and toes is treatment early in the disease. 
 Loss of function and disability: Rheumatoid joint inflammation affects tissues 
surrounding the joint, including tendons, ligaments, and muscles that stabilize 
joints. This weakens the joints and can lead to a loss of function and disability. 
 Osteoporosis: People who have rheumatoid arthritis are at increased risk for the 
bone-thinning condition osteoporosis. Bone loss associated with the 
inflammation of rheumatoid arthritis is one cause for this increased risk. Joint 
damage and disability may also contribute to inactivity, which increases the risk 
of osteoporosis. Moreover, corticosteroids that are used to treat rheumatoid 
inflammation can also promote bone loss. 
 Coronary artery disease: People who have rheumatoid arthritis have an increased 
risk of coronary artery disease (hardening of the arteries to the heart) compared 
to those who don't have rheumatoid arthritis. Inflammation is associated with 
both rheumatoid arthritis and coronary artery disease. Researchers suspect that 
inflammation related to rheumatoid arthritis triggers the buildup of plaque in the 
arteries. 
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 Anemia: Many people who have rheumatoid arthritis may also have anemia, a 
condition in which the body lacks enough red blood cells. Red blood cells are 
needed to deliver oxygen to the body tissues. Anemia often causes fatigue and 
other symptoms. The inflammation of chronic rheumatoid arthritis decreases the 
formation of red blood cells in the bone marrow, which leads to anemia. 
 Early death: Untreated rheumatoid arthritis increases the risk of mortality. 
People who have untreated rheumatoid arthritis are twice as likely to die 
compared to age-matched controls that do not have the disease. At least 25% of 
people with RA die from cardiovascular disease, and another 25% die from 
infections. 
 Depression and nervous system: People with RA commonly develop depression. 
Changes in behavior, cognitive dysfunction, problems with peripheral nerves, 
and spinal cord compression may also occur. The inflammatory process of RA 
affects the brain and nerves, which leads to neuropsychiatric symptoms. 
Others 
Osteoporosis: Some medications used for treating rheumatoid arthritis,can increase risk 
of osteoporosis which is a condition that weakens bones and makes them more prone to 
fracture. 
Carpal tunnel syndrome: If RA affects wrists the inflammation can  compress the nerve 
that serves most of hand and fingers 
Heart problems: RA can increase risk of hardened and blocked arteries, as well as 
inflammation of the sac that encloses heart 
Lung disease: People with RA have an increased risk of inflammation and scarring of 
the lung tissues, which can lead to progressive shortness of breath. 
Investigation
 [37] 
1. Haematological: 
a) ESR- increased in active stage. 
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Determination of erythrocyte sedimentation rate by Westergren method is a 
sensitive indicator of the presence of systemic or locally severe 
inflammation  
b) Serum protein-Hyper globulinaemia with elevation of gamma &alpha-2 
globulin and hypoalbuminaemia during active phase. 
 TRBC 
 TWBC 
 Platelets 
 ESR 
 RF 
 CRP  
 Antinuclear antibodies (ANA) 
 Anti-CCP.  
Rheumatoid factor 
Rheumatoid factor is an immunoglobulin M (IgM) antibody diretced against 
normal human immunoglobulin it is usually measured by agglutination test (IgG). 
(Agglutination of IgG coated latex particles) and reported as either negative or positive 
with titres up to 1:320. 
The rheumatoid factor is an antibody present in the blood of many patients with 
rheumatoid arthritis. Doctors measure the level of rheumatoid factor by performing a 
blood test. A positive rheumatoid factor test means that the patient‘s level of rheumatoid 
factor in their blood is considered high. 
Rheumatoid factor was first described in connection to rheumatoid arthritis in 
1940. For decades, a positive rheumatoid arthritis test was used to diagnose those with 
symptoms of rheumatoid arthritis. 
Today, a positive rheumatoid factor test is mostly used as a supportive tool in 
helping doctors reach a diagnosis. Yet, it must be combined with other tools and 
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criteria. A positive rheumatoid factor test is also used to determine a general prognosis 
for rheumatoid arthritis in adults and children. 
All immune systems contain healthy antibodies that fight off infections caused 
by bacteria and viruses. Sometimes, however, bad antibodies are produced by the 
immune system which can attack healthy antibodies. In other words, the antibodies turn 
against the person‘s system damaging their health. 
When antibodies begin to attack the person, it can result in triggering an immune 
response. This immune response can turn into an autoimmune disorder which in turn 
can produce a variety of different symptoms, ultimately damaging that person‘s health. 
Rheumatoid factor is a bad protein antibody produced by a person‘s immune 
system. If triggered, rheumatoid factor antibodies attack the healthy tissue in the 
patient‘s body. Rheumatoid factor attacks result in a variety of inflammatory symptoms. 
Typically, these symptoms cause inflammation in the synovium of the patient‘s 
joints, which leads to rheumatoid arthritis. Rheumatoid factor can also cause other 
symptoms seen in autoimmune disorders like Sjogren‘s Syndrome or Hepatitis C. 
The reason rheumatoid factor is commonly associated with rheumatoid arthritis 
specifically is because when the antibody was discovered it was used to diagnose 
rheumatoid arthritis. Approximately 80% of adult rheumatoid arthritis patients test 
positive for rheumatoid factor. However, people without any autoimmune disorders can 
also test positive for rheumatoid factor. 
It is unknown what causes rheumatoid factor to develop in someone‘s blood. It 
is thought to be however a combination of genetics and other external risk factors. 
Certain people have low levels of rheumatoid factor, which may not ever be enough to 
trigger an autoimmune response. 
On the other hand, some people have high levels of rheumatoid factor and go on 
to develop autoimmune disorders like rheumatoid arthritis. It isn‘t known what triggers 
the autoimmune response that causes rheumatoid arthritis. 
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Testing for rheumatoid factor is like any other blood test. The rheumatoid factor 
test is done by drawing blood and analyzing it for the presence of this particular protein 
antibody. If the results show a certain level of rheumatoid factor, then the test reads 
positive for rheumatoid factor. Rheumatoid factor tests can also detect lower levels of 
rheumatoid factor that don‘t result in it being declared a positive reading. 
Testing positive for rheumatoid does not necessarily mean the patient has 
rheumatoid arthritis. A positive for rheumatoid factor test results means that it can lead 
to or is the cause of inflammatory symptoms from an autoimmune disorder. In certain 
cases, however, patients may test positive for rheumatoid factor and remain healthy 
never to experience symptoms. 
Rheumatoid factor can be present in patients several months or even years 
before clinical rheumatoid arthritis symptoms develop. Depending on the level of 
symptoms a patient exhibits, the rheumatoid factor test results can assist doctors in 
reaching a rheumatoid arthritis diagnosis. 
The amount of rheumatoid factor in blood can be measured in two ways: 
 Agglutination tests. One test method mixes blood with tiny rubber (latex) 
beads that are covered with human antibodies. If RF is present, the latex 
beads clump together (agglutinate). This method is best used as a first-time 
screening test for rheumatoid arthritis. Another agglutination test mixes the 
blood being tested with a sheep's red blood cells that have been covered with 
rabbit antibodies. If RF is present, the red blood cells clump together. This 
method is often used to confirm the presence of RF. 
 Nephelometry test. This test mixes the blood being tested with antibodies 
that cause the blood to clump if RF is present. A laser light is shined on the 
tube containing the mixture, and the amount of light blocked by the blood 
sample is measured. As levels of RF increase, more clumping occurs, 
causing a cloudier sample and less light to pass through the tube. 
Positive rheumatoid factor results in someone who has been clinically diagnosed 
with rheumatoid arthritis may also indicate the potential for a more aggressive disease 
course. This is possible in both children and adult patients. 
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Patients who test negative for rheumatoid factor but still exhibit symptoms and 
meet other diagnostic criteria may still be diagnosed with rheumatoid arthritis. 
Patients who test positive for rheumatoid factor aren‘t necessarily diagnosed 
with rheumatoid arthritis right away. There must also be a clear history of consistent 
rheumatoid arthritis symptoms. 
Suspects symptoms of rheumatoid arthritis, other criteria must first be taken into 
consideration before reaching a diagnosis. The presence of rheumatoid factor alone does 
not typically lead to an immediate rheumatoid arthritis diagnosis. Doctors look at 
physical symptoms, medical history and may conduct other blood tests, like anti-CCP, 
and imaging scans to help identify the condition. 
Depending on the final diagnosis, the presence of rheumatoid factor in a 
patient‘s blood may help determine the type of treatment that will be provided to that 
patient, such as disease-modifying antirheumatic drugs (DMARDs). 
A positive rheumatoid factor test along with a rheumatoid arthritis diagnosis can 
potentially help the doctor determine a prognosis, although this depends on a variety of 
factors. Determining a prognosis for rheumatoid arthritis patients is difficult. The 
disease affects different people in different ways. A prognosis can depend largely on the 
types of symptoms the patient displays as well as their medical history. 
Many doctors and researchers feel that a positive rheumatoid factor test result 
may predict a more severe pattern of symptoms and overall disease course. Extra-
articular symptoms like rheumatoid nodules may be more likely to form in patients who 
have positive rheumatoid factor blood test results. Other aggressive symptoms, though 
rare, could be more likely to occur in rheumatoid factor positive patients. These may 
include lung and heart conditions. 
Rheumatoid factor positive patients may also have a higher disease activity 
score, meaning frequent flare-ups and fewer remission periods. Keep in mind this isn‘t 
always the case. If rheumatoid factor is tested and symptoms are detected early, a 
diagnosis can be quickly reached. Treatment can begin as soon as possible to prevent 
further progression of joint damage, swelling and pain. 
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a) Rose waaler test: 
    A special type of passive haem agglutination test is rose waaler test. In 
RA autoantibodies appears in the serum, which acts as an antibody to 
gamma globulin. The RA factor is able to agglutinate red cells coated with 
globulin. The antigen used for the test is suspension of sheep erythrocytes 
sensitized with subagglutinating dos of rabbit anti-sheep erythrocyte 
antibody. (amboceter). 
b)   Latex agglutination test (latex fixation test) 
c)   Differential agglutination test(DAT) 
d)   Human erythrocyte agglutination test(HEAT) 
e)   Anti-nuclear antibodies. 
  Routine determination of the presenceof anti-nuclear antibodies is 
  performed by the indiretc immunofluorescent technique. 
C reactive protein 
[38] 
CRP is produced in the liver and is normally found in serum in minute amounts 
(less than 0.6 mg/dl). In conditions characterized by inflammation with tissue 
destruction, the CRP level may increase. Although CRP has many effects in the immune 
system, its specific primary role is still unclear.
  
C-reactive protein (CRP) is a substance produced by the liver in response to 
inflammation. Other names for CRP are high-sensitivity C-reactive protein (hs-CRP) 
and ultra-sensitive C-reactive protein (us-CRP).
 
A high level of CRP in the blood is a marker of inflammation. It can be caused 
by a wide variety of conditions, from infection to cancer. High CRP levels can also 
indicate that there‘s inflammation in the arteries of the heart, which can mean a higher 
risk for heart attack. However, it‘s important to remember that the CRP test is an 
extremely nonspecific test, and CRP levels can be elevated in any inflammatory 
condition. 
C-reactive protein is measured in milligrams of CRP per liter of blood (mg/L). 
In general, a low C-reactive protein level is better than a high one, because it indicates 
less inflammation in the body. 
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According a reading of less than 1 mg/L indicates you‘re at low risk of 
cardiovascular disease. A reading between 1 and 2.9 mg/L means you‘re at intermediate 
risk. A reading greater than 3 mg/L means you‘re at high risk for cardiovascular disease. 
A reading above 10 mg/L may signal a need for further testing to determine the cause of 
such significant inflammation in your body. 
A CRP reading of greater than 10 mg/L is especially high and may indicate: 
 a bone infection, or osteomyelitis 
 an autoimmune arthritis flare-up 
 tuberculosis 
 lupus, connective tissue disease, or other autoimmune diseases 
 cancer, especially lymphoma 
 pneumonia or other significant infection 
Note that CRP levels may also be elevated if you‘re on birth control pills. 
However, other markers of inflammation are not necessarily abnormal in these 
individuals. Elevated CRP values in pregnancy may be a marker for complications, but 
more studies are necessary to fully understand the role of CRP and pregnancy.  
If pregnant or have any other chronic infection or inflammatory disease, a CRP 
test is unlikely to accurately assess your risk for heart disease. Before having a CRP 
test, speak to your doctor about any medical conditions that may skew the test results. 
Since there are other blood tests that can be performed instead, you might wish to 
forego a CRP test altogether. 
Anti-citrullinated protein antibodies (ACPA) or anti-cyclic citrullinated protein 
antibodies (anti-CCP) are autoantibodies (antibodies directed against one or more of an 
individual‘s own proteins) that are frequently detected in the blood of rheumatoid 
arthritis patients. 
ANA
 
The antinuclear antibody (ANA) test is used as a primary test to help evaluate a 
person for autoimmune disorders that affect many tissues and organs throughout the 
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body (systemic) and is most often used as one of the tests to help diagnose systemic 
lupus erythematosus (SLE). 
ANA are a group of autoantibodies produced by a person's immune system 
when it fails to adequately distinguish between "self" and "nonself." They target 
substances found in the nucleus of a cell and cause organ and tissue damage. Depending 
on a person's signs and symptoms and the suspected disorder, ANA testing may be used 
along with or followed by other autoantibody tests. Some of these tests are considered 
subsets of the general ANA test and detect the presence of autoantibodies that target 
specific substances within cell nuclei, including anti-dsDNA, anti-centromere, anti-
nucleolar, anti-histone and anti-RNA antibodies. An ENA panel may also be used in 
follow up to an ANA. 
These supplemental tests are used in conjunction with a person's clinical history 
to help diagnose or rule out other autoimmune disorders, such as Sjogren syndrome, 
polymyositis and scleroderma. 
Different laboratories may use different test methods to detect ANA. Two common 
methods include immunoassay and indirect fluorescent antibody (IFA). IFA is 
considered the gold standard. Some laboratories will use immunoassay to screen for 
ANA and use IFA to confirm positive or equivocal results. 
 Indirect fluorescent antibody (IFA)—this is a method in which a person's blood 
sample is mixed with cells that are affixed to a slide. Autoantibodies that may be 
present in the blood react with the cells. The slide is treated with a fluorescent 
antibody reagent and examined under a microscope. The presence (or absence) 
and pattern of fluorescence is noted. 
 Immunoassays--these methods are usually performed on automated 
instrumentation but may be less sensitive than IFA in detecting ANA. 
Other laboratory tests associated with the presence of inflammation, such as 
erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP), may also be used 
to evaluate a person for SLE or other autoimmune disease. The ANA test is ordered 
when someone shows signs and symptoms that are associated with a systemic 
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
43 
autoimmune disorder. People with autoimmune disorders can have a variety of 
symptoms that are vague and non-specific and that change over time, progressively 
worse, or alternate between periods of flare ups and remissions. Some examples of signs 
and symptoms include: 
 Low-grade fever 
 Persistent fatigue, weakness 
 Arthritis-like pain in one or more joints 
 Red rash (for lupus, one resembling a butterfly across the nose and cheeks) 
 Skin sensitivity to light 
 Hair loss 
 Muscle pain 
 Numbness or tingling in the hands or feet 
 Inflammation and damage to organs and tissues, including the kidneys, 
lungs, heart, lining of the heart, central nervous system, and blood vessels 
A positive ANA test result means that autoantibodies are present. In a person with 
signs and symptoms, this suggests the presence of an autoimmune disease, but further 
evaluation is required to assist in making a final diagnosis. 
Tests for ANA 
 Immunoassay (enzyme linked immunosorbent assay, ELISA, or enzyme 
immunoassay, EIA)—the results are usually reported as a number with an 
arbitrary unit of measure (abbreviated as a "U" on the report, for example). 
 Indirect fluorescent antibody (IFA)—the results of this method are reported 
as a titre. Titers are expressed as ratios. For example, the result 1:320 means 
that one part blood sample was mixed with 320 parts of a diluting substance 
and ANA was still detectable. 
In addition to a titer, positive results on IFA will include a description of the particular 
type of fluorescent pattern seen. Different patterns have been associated with different 
autoimmune disorders, although some overlap may occur. Some of the more common 
patterns include: 
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 Homogenous (diffuse) associated with SLE, mixed connective tissue 
disease, and drug-induced lupus 
 Speckled associated with SLE, Sjgren syndrome, scleroderma, polymyositis, 
rheumatoid arthritis, and mixed connective tissue disease 
 Nucleolar associated with scleroderma and polymyositis 
 Centromere pattern (peripheral) associated with scleroderma and CREST 
(Calcinosis, Raynaud syndrome, Esophogeal dysmotility, Sclerodactyly, 
Telangiectasia) 
A positive result from the ELISA or EIA method will be a number of units that is above 
the laboratory's reference number (cutoff) for the lowest possible value that is 
considered positive. An example of a positive result using the IFA method would give 
the dilution titer and a description of the pattern, such as "Positive at 1:320 dilution with 
a homogenous pattern." 
For either method, the higher the value reported, the more likely the result is a 
true positive. ANA test results can be positive in people without any known 
autoimmune disease and thus need to be evaluated carefully in conjunction with an 
individual's signs and symptoms. 
An ANA test may become positive before signs and symptoms of an 
autoimmune disease develop, so it may take time to tell the meaning of a positive ANA 
in a person who does not have symptoms. 
Conditions associated with a positive ANA test 
The most common condition is SLE. 
 SLE- ANA are most commonly seen with SLE. About 95% of those with SLE 
have a positive ANA test result. If someone also has symptoms of SLE, such as 
arthritis, a rash, and skin sensitivity to light, then the person probably has SLE. 
A positive anti-dsDNA and anti-SM (often ordered as part of an ENA panel) 
help confirm that the condition is SLE. 
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Other conditions in which a positive ANA test result may be seen include: 
 Drug-induced lupus - a number of medications may trigger this condition, which 
is associated with SLE symptoms. When the drugs are stopped, the symptoms 
usually go away. Although many medications have been reported to cause drug-
induced lupus, those most closely associated with this syndrome include 
hydralazine, isoniazid, procainamide, and several anticonvulsants. Because this 
condition is associated with the development of autoantibodies to histones, an 
anti-histone antibody test may be ordered to support the diagnosis. 
 Sjogren syndrome - 40-70% of those with this condition have a positive ANA 
test result. While this finding supports the diagnosis, a negative result does not 
rule it out. A health practitioner may want to test for two subsets of ANA: Anti-
SS-A (Ro) and Anti-SS-B (La). About 90% or more of people with Sjögren 
syndrome have autoantibodies to SSA. 
 Scleroderma (systemic sclerosis) - About 60-90% of those with scleroderma 
have a positive ANA. In people who may have this condition, ANA subset tests 
can help distinguish two forms of the disease, limited versus diffuse. The diffuse 
form is more severe. The limited form is most closely associated with the 
anticentromere pattern of ANA staining (and the anticentromere test), while the 
diffuse form is associated with autoantibodies to Scl-70. 
 Less commonly, ANA may occur in people with Raynaud syndrome, arthritis, 
dermatomyositis or polymyositis, mixed connective tissue disease, and other 
autoimmune conditions. For more on these, read the article on Autoimmune 
Diseases. 
A health practitioner must rely on test results, clinical symptoms, and the 
person's history for diagnosis. Because symptoms may come and go, it may take months 
or years to show a pattern that might suggest SLE or any of the other autoimmune 
diseases. 
A negative ANA result makes SLE an unlikely diagnosis. It usually is not 
necessary to immediately repeat a negative ANA test; however, due to the episodic 
nature of autoimmune diseases, it may be worthwhile to repeat the ANA test at a future 
date if symptoms recur. 
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Aside from rare cases, further autoantibody (subset) testing is not necessary if a 
person has a negative ANA result. 
ANA testing is not used to track or monitor the clinical course of SLE, thus 
serial ANA tests for diagnosed patients are not commonly ordered. 
Use of a number of drugs, some infections, autoimmune hepatitis and primary 
biliary cirrhosis as well as other conditions mentioned above can give a positive result 
for the ANA test. 
About 3-5% of healthy Caucasians may be positive for ANA, and it may reach as high 
as 10-37% in healthy individuals over the age of 65 because ANA frequency increases 
with age. These would be considered false-positive results because they are not 
associated with an autoimmune disease. Such instances are more common in women 
than men. 
Anti – CCP  
CCP (cyclic citrullinated peptide) antibody is an autoantibody against 
citrullinated proteins (ACPA). The anti-CCP test is able to detect the autoantibodies 
against citrullinated proteins which have a relatively high sensitivity (reportedly 
between 50 and 75 percent) for rheumatoid arthritis and extremely high specificity 
(about 90 percent) for rheumatoid arthritis. Its high specificity is why the anti-CCP test 
has become an important part of the diagnostic process for rheumatoid arthritis. 
Anti-CCP Test: Its Diagnostic and Prognostic Value 
Anti-CCP test helps to distinguish rheumatoid arthritis from other inflammatory 
types of arthritis. It is also extremely valuable in diagnosing people who are 
seronegative for rheumatoid factor. Not only does the anti-CCP test have diagnostic 
value, it also has prognostic value. If anti-CCP is present at a moderate to high level, it 
not only helps to confirm the diagnosis, it suggests there may potentially be a more 
destructive and severe disease course (i.e., progressive joint damage). Low levels of the 
antibody are not as telling or predictive. 
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Usually, the anti-CCP test is ordered along with the rheumatoid factor test, since 
neither test alone can definitively confirm the diagnosis of rheumatoid arthritis. 
According to rheumatologist Scott J. Zashin, MD, "While rheumatoid factor is more 
common in people who have rheumatoid arthritis, there are people who are positive for 
rheumatoid factor who do not have rheumatoid arthritis. 
Furthermore, the presence of the rheumatoid factor has less prognostic 
significance than ACPA. Also, if a person is negative for rheumatoid factor, they are 
less likely to be positive for ACPA." 
Identifying Autoantibodies 
The importance of identifying autoantibodies in rheumatic diseases had been 
recognized for decades, but identifying those that were clinically relevant in terms of 
specificity and sensitivity took time. There have been three generations of the anti-CCP 
test. With each generation of testing the specificity and sensitivity have improved. 
According to Kelley's Textbook of Rheumatology, more than 90 percent of 
people with undifferentiated arthritis who test positive for anti-CCP develop rheumatoid 
arthritis within 3 years. Only about 25 percent of those with undifferentiated arthritis 
who test negative for anti-CCP develop rheumatoid arthritis. 
Autoantibodies may be detectable before the clinical onset of certain 
autoimmune diseases, including rheumatoid arthritis. Autoantibodies can precede the 
onset of seropositive rheumatoid arthritis by 2 to 6 years, according to Kelley's 
Textbook of Rheumatology. Reportedly, anti-CCP that precedes the diagnosis of 
rheumatoid arthritis is twice as prevalent as rheumatoid factor that precedes the 
diagnosis. While rheumatoid factor usually remains consistently present, the presence of 
anti-CCP can vary in rheumatoid arthritis patients—even disappearing in some cases. 
Significance of Anti-CCP 
As researchers work to determine the cause (i.e., etiology and pathogenesis) of 
rheumatoid arthritis, defining which antigens promote the formation of autoantibodies 
against citrullinated proteins is an important task. 
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Peptidylarginine deiminase (PAD) enzymes, which catalyze the conversion of 
peptidylarginine to peptidylcitrulline, have a significant role in generating autoantigens 
in rheumatoid arthritis. Also, more research is needed to determine what causes the pre-
symptomatic phase of rheumatoid arthritis to shift into a symptomatic, full-fledged 
disease process.  
While the specificity of anti-CCP is very high for rheumatoid arthritis, positive 
results can occur with other autoimmune rheumatic diseases, tuberculosis, and chronic 
lung disease. Anti-CCP antibodies have been reported in systemic lupus erythematosus 
and primary Sjogren's syndrome, typically when erosive arthritis is present. 
It has also been found in up to 16 percent of people with psoriatic arthritis- most 
often with erosive or polyarthritis. Sometimes, it accompanies severe psoriasis without 
arthritis.   
Anti-CCP antibodies are a highly specific marker for RA in several diverse 
patient groups. This specificity extends to patients with early disease, in whom a timely 
diagnosis is most needed. The low sensitivity of the test (40–50% in most published 
cohorts) indicates that a negative anti-CCP antibody test does not exclude disease, but 
its high specificity means that a positive result markedly increases the probability that 
the patient will have RA. Anti-CCP antibodies also identify a subset of patients who are 
likely to have substantial ongoing disease activity, accrue more damage, and who will 
probably benefit most from early aggressive treatment. A significant number of these 
patients do not have rheumatoid factor, and may not otherwise have been expected to 
develop severe aggressive disease. Anti-CCP antibodies tend to remain stable or decline 
slightly with treatment, and have not been found frequently in non-RA inflammatory or 
arthritic diseases. The presence of anti-CCP antibodies in serum years before the onset 
of RA suggests the possibility of pre-clinical detection, and may provide information 
about early events in the pathogenesis of the disease.
 
Special investigation
 
      Synovial fluid analysis confirms the presence of the inflammatory arthritis. Fluid 
may show positive rose-waaler test in joint fluid before it can be detected in blood. Also 
it may show neutrophils or monocytes containing cytoplasmic inclusion bodies. 
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Gross test of inflammation in synovial fluid found in patient with RA has a WBC count 
of greater than 2000/cumm and may be either translucent or opaque. 
Synovial membrane biopsy 
      Villus formation with thickening of synovial layer and infiltration with abnormal 
cells. 
Radiographic evaluation 
      The primary value of radiography is to determine the extent of cartilage destruction 
and bone erosion produced by the disease. 
Stages of x ray progression in RA 
 Peri articular osteoporosis. 
 Loss of articular cartilage(joint space) 
 Erosions  
 Subluxation and ankylosis 
Arthroscopy 
    In acute RA synovium is odematous, diffusely erythematous and friable. In more 
chronic conditions, it becomes thickened. 
Renal biopsy 
        Indicated in cases of reduced tubular or glomerular function. 
Pulmonary biopsy 
          Used to distinguishing rheumatoid nodules from carcinoma or to establish 
diagnosis of fibrosing alveolitis. 
Others 
 Ultra sound                 
 Biochemical analysis 
 Urine analysis              
 CT Scanning 
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 Scintigraphy                 
 MRI 
 Treatment 
[39] 
  Drugs used in the treatment of Rheumatoid arthritis are 
I. NSAIDS 
 Aspirin 
 Ibuprofen 
 Diclofenac 
 Naproxen 
 Piroxicam 
II. DMARDs 
1. Immunosuppressants: 
 Methotrexate 
 Cyclophosphamide 
 Azathioprine 
 Cyclosporine 
 Leflunomide 
2. Biological agents: 
 TNF – alpha blockers 
 Ethanercept 
 Infliximab 
 Adalimumab 
 Inhibitors of T cell activation 
 Abataceot 
 IL – 1 antagonist 
 Anakinra 
 Anti B lymphocyte antibody 
 Rituximab  
3. Gold salts:  
 Auronofin 
 Aurothiomalate 
4. Others:  
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 Penicillamine 
 Sulphasalazine 
 Chloroquine 
 Hydroxychloroquine 
III. Adjuvants: 
 Glucocorticoids 
    3.3. PHARMACEUTICAL REVIEW 
CHOORANAM 
Definition 
Chooranam is a fine powder s of drugs. The ―Chooranam‖ may be applied to the 
powders of a single drug or a mixture of two or more drugs, which are powdered 
separately prior to their being mixed to homogeneity.  
Method of preparation 
Equipment required 
1. The drug enumerated in the recipe in clean and well dried state. 
2. A mortar and pestle. 
3. A fine sieve or fine cloth of close mesh. 
Process of preparation 
The drugs which are to be used in the preparations should be taken from recently 
collected material. Drugs which are aged by prolonged storages or changed in colour, 
taste and scent, and those that are insects infested or attacked by fungi should be 
positively rejected. 
However drugs like Embelia fruits, Senna, Long Pepper, Jaggery and cows ghee 
are preferred from fairly aged stock, provided they are not infested with pests, 
deteriorated or spoiled or developed racidity. 
In general the aromatic drugs are slightly fried in order to enhance their aroma 
and milling properties. Any extraneous material, organic or inorganic, should be 
removed from the drugs by close inspection. 
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The Chooranam should be so fine to be called amorphous and should never be 
damp. The fineness of the sieve should be 100 mesh or still finer. 
Purification of the prepared chooranam 
 ோசனன்ம சூ஭ணத் ின் சுத் ிக்தகளு 
 ப்போத  ச஭க்சகல்யோஞ் சூ஭ணித்து 
நோசனன்ம லோலின் போயோற் பிலசந்து 
நய஫ோன சட்டி஬ிதய போலயலிட்டு 
லோசனன்ம சுத் சயம் போ ிலிட்டு 
லர஫ோக த஫ற்சீலய தகோடு கட்டிப் 
போசனன்ம சூ஭ணத்ல ப் பிட்டுதபோல் லலது 
ப மோத  சலந்ச டுக்கச் சித் ி஬த஫! 
- அகஸ் ி஬ர் லலத் ி஬ இ஭த் ினச் சுருக்கம் 
  
The prepared chooranam is mixed with the milk in pot half quantity milk and 
half quantity water is taken. The mouth of the pot is covered with a thin cloth material. 
Above this cloth the mixed chooranam is placed. The pot is placed over the stove and 
heated. 
ஆ஫ப்போ ஭லிம௃யர்த் ிப் சபோடி ோன் சசய்து 
அப்பதன ச஫னோய்ச் சர்க்கல஭ல஬ச்தசர்த்து 
நோ஫ப்போ சகோண்டு ல஭ த ோளம் தபோச்சு 
நன்மோக்ச் சுத் ி சசய்஬ோச் சூ஭ணந் ோன் 
 ோ஫ப்போ த஭ோகத்ல  சலல்யோ ப்போ  
 ர஫ோன லி஬ ி ச஬ல்யோம் போரிக்கும் போர் 
தல஫ப்போ சுத் ி சசய்து சகோண்டோ஬னோல் 
சலகுசுறுக்கோய் ீரு஫ோ லி஬ோ ி தகளு 
- அகஸ் ி஬ர் லலத் ி஬ இ஭த் ினச் சுருக்கம் 
-  
Then the Chooranam is placed in the sunlight and powdered. Equal amount of 
sugar is added and taken internally. All type of diseases get cured. If the drug is taken 
without purification the disease does not cure. If taken after purification the disease 
cures easily. 
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Storage 
The prepared Chooranam should be allowed to cool by spreading and mixing, 
prior to packing. They should be stored in tightly stoppered glass, polythene or tin 
containers, or in polythene or cellophane bags and sealed. These bags should in turn be 
enclosed in cardboard boxes. 
The Chooranam to facilitate easy handling and to assure exact dosage 
administration, could be pressed into tablets, could be packed in bottles or tubes made 
either of glass or plastic or packed in strip of metal foil or plastic sheets. 
In industry the tablets are made, counted & packed by electronic devices. 
Then Chooranam is said to retain its potency for 2 months and then gradually 
deteriorate. However if properly packed & stored they keep good for a year.  
According to AYUSH guidelines shelf life of Chooranam is one year. 
 
  
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
54 
             Table No: 1 Analytical specifications of Churna/Choornam
 [40]
  
Sl.No TESTS 
1. 
 
2. 
3. 
4. 
5. 
6. 
7. 
 
8. 
 
9. 
 
 
 
 
10. 
 
 
11. 
 
 
 
 
12. 
 
 
 
13 
Description 
Macroscopic, Microscopic 
Loss on drying at 1050 C 
Total – ash 
Acid – insoluble ash 
Water-soluble extractive 
Alcohol – soluble extractive 
Particle size (80-100 mesh for Churna; 40-60 
mesh  for churna) 
Identifications, TLC/HPTLC-with marker (wherever 
possible) 
Test for heavy/Toxic metals 
Lead 
Cadmium 
Mercury 
Arsenic 
Microbial contamination 
Total bacterial count 
Total fungal count 
Test for specific Pathogen 
E. coli 
Salmonella spp. 
S.aureus 
Pseudomonas aeruginosa 
Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
Test for Aflatoxins (B1,B2,G1,G2) 
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                                3.4. PHARMACOLOGICAL REVIEW 
EVALUATION OF ANALGESIC ACTIVITY  
A) Acetic acid induced writhing test 
Principle 
Painful reactions in animals may be produced by chemicals also. Intraperitoneal 
injection of phenylquinone, bradykinin or acetic acid produces pain reaction which is 
characterized as a writhing response.Abdominal constriction,turning of trunk(twist) and 
extension of hind legs(stretching) responses by the animal are taken as reaction to 
chemically induced pain. Analgesics both narcotic and non-narcotic type, inhibit 
writhing response.  
Procedure  
Swiss albino mice were divided into four groups (n = 6). Group I received acetic 
acid (1% v/v, 10 ml/kg b.w., i.p.) and writhing reflex was noted for the period of 15 
minutes. Group II received aspirin (100 mg/kg b.w.p.o.) Group III and IV received trial 
drug at the doses of 100 mg/kg and 200 mg/kg b.w., p.o. respectively. 30 min after 
aspirin and trial drug administration, group II and III received acetic acid (1% v/v, 10 
ml/kg b.w., i.p.) and writhing reflex was noted for the period of 15 min. 
[41, 42] 
Writhing test is a chemical method used to induce pain of peripheral origin by 
injection of irritant principles like phenylquinone, acetic acid in mice. Analgesic activity 
of the test compound is inferred from decrease in the frequency of writhings. The 
manifestations of abdominal writhings in mice were first described by Sigmund et al as 
an arching of back, extension of hind limbs and contraction of abdominal musculature. 
The writhing response is considered as a reflexive test and is without clinical 
counterparts as it cannot be performed in human and sensations involved are unknown. 
Further, authors pointed out that the writhing test produced severe pain in mice which 
raises ethical concern regarding its use. Stevens has commented on the report of one 
pharmaceutical company, Warner–Lambert Research Institute, Morris Plains N.J. which 
company has conducted about 100 experiments on 5000 mice. 0.1 ml of phenylquinone 
was injected intraperitoneally to induce writhing and animals began stretching their 
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abdomen in few minutes. He wrote that writhing, of course, means agony, a standard 
test that should not be tolerated in any civilized country. 
Writhings generated by parenteral administration of acetic acid in mice, are due 
to profound pain of endogenous nature which recur for a prolonged period of time. Due 
to irritant nature, these principles are also prone to induce lesions. Writhing is an overt 
response to the intense pain induced by irritant principles via nociceptors characterized 
by episodes of retraction of abdomen and stretching of hind limbs. The signals 
transmitted to central nervous system in response to pain due to irritation, cause release 
of mediators such as prostaglandins which contributes to the increased sensitivity to 
nociceptors. Writhing test was in practice for the evaluation of analgesic effect till 2004. 
However, the test was withdrawn from Sept. 2004, soon after implementation of report 
of ministry of environmental and forest, animal welfare division, Govt. of India. In 
CPCSEA report it was stated that laboratory animals used for the experimentation 
should be properly used and pain and sufferings inflicted in animals should be avoided 
or minimized if avoidance is not possible. Scientists and investigators should proceed 
on the basis that experimental procedures that cause pain or sufferings in human beings 
will also cause similar pain or sufferings in animals. 
Despite government's decision, number of scientific journals publish papers in 
which writhing test is employed. It is suggestive to kindly adhere to the government's 
notification of avoidance of tests causing longer lasting painful infliction and to perform 
in this context, triple analgesic test using thermal, mechanical and electrical methods in 
which animals are exposed to momentary pain or sufferings. The inferences drawn from 
these tests can be used to evaluate analgesic effect of new active principles.
  
B) Hot plate assay 
Principle 
In this method heat is used as a source of pain. Animals are individually placed 
on a hot plate maintained at constant temperature (55
0
C) and the reaction of animals 
such as paw licking or jump response is taken as the end point. Analgesic increases the 
reaction-time. The method was first described by Eddy and Leimbach. 
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Procedure 
     Four groups of mice (n = 6) were treated orally with trial drug (100 and 200 mg/kg 
b.w. p.o.), morphine sulphate (10 mg/kg b.w. p.o.) and normal saline (5 ml/kg b.w.). 
Mice were placed on a hot plate (Bibby Sterilin, UK) maintained at 55 ± 1°C and the 
reaction latency (in seconds) for licking of hind paw or jumping noted. The mice which 
reacted within 15 sec and which did not show large variation when tested on four 
separated occasions were selected for studies. Recordings were taken before treatment 
with the different drugs and 1, 2, 3, 4, 5 h post treatment. Results were expressed as the 
difference between the baseline reaction latency and the reaction latency at recorded 
times
 [43, 44]. 
  During the experiment, the rat or mouse is introduced into an open-ended 
cylindrical space with a floor consisting of a heated plate. The plate heated to a constant 
temperature produces two behavioral components that can be measured in terms of their 
reaction times, namely paw licking and jumping. Both are considered to be 
supraspinally integrated responses. 
  One particularity of this test is that it can only be performed once in each animal 
when the jumping response is evaluated. Indeed, when the animal is exposed to the first 
time to the test, it learns that the experimenter takes it out of the plate as soon as the 
jumping behavior is done. So, when the animal is place again on the plate, it jumps after 
some few seconds without performing the primary licking responses. 
C) Tail-flick method: 
Principle 
    Analgesia is defined as a state of reduced awareness to pain, and analgesica are 
substance which decrease pain sensation (pain-killers) by increasing threshold to painful 
stimuli. The commonly used analgesics are aspirin, paracetamol (non-norcotic type) and 
morphine. (narcotic type)  
     Painful reaction in experimental animals can be produced by applying noxious 
(unpleasant) stimuli such as  
1. Thermal (radiant heat as a source of pain).  
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2. Chemical (irritant such as acetic acid and bradykinin)  
3. Physical pressure (tail compression).  
In laboratory, commonly used procedures are tail flick (tail withdrawal from the 
radiant heat) method using analgesiometer, hot plate (jumping from the hot plate at 
55
0
C) method and acetic acid induced writhing. 
[45, 46] 
D) Formalin assay 
The formalin test was carried out as described by previous workers. Four groups 
of mice (n = 6) were treated orally with trial drug (100 and 200 mg/kg), aspirin (100 
mg/kg) and normal saline (5 ml/kg b.w.). Formalin solution (1% v/v) was injected into 
the sub-plantar region of the right hind paw of the animals 30 min post treatment. The 
number of times paw was licked/bitten within the time frames of 0-5 min (neurogenic 
phase) and 15-30 min (inflammatory phase) after formalin administration was counted. 
[47, 48] 
EVALUATION OF ANTI-INFLAMMATORY ACTIVITY 
A) Carrageenan induced rat paw oedema 
Principle 
Inflammation is a tissue-reaction to infection, injury, irritation or foreign 
substance. It is a part of the host defence mechanism but when it becomes uncontrolled 
it is a hopeless condition. Aging is also considered to be an inflammatory response. 
There are several tissue factors or mechanism that are known to be involved in the 
inflammatory reactions such as release of histamine,bradikinin and prostaglandins. The 
development of non-steroidal anti –inflammatory agents in recent years has contributed 
a lot in not only overcoming the human suffering such as arthritis but also has helped in 
understanding the tissue mechanisms of inflammation. The student is advised to study 
the pathophysiology and the mechanism of action of anti-inflammatory drugs before 
performing this experiment for better understanding. 
    The inflammatory reaction is readily produced in rats in th form of paw oedema 
with the help of irritants. Substances such as carrageenan,formalin,bradykinin, 
histamine, 5 –hydroxytryptamine, mustard, or egg white when injected in the dorsum of 
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
59 
the foot of rats they produce acute paw edema within a few minutes of the injection. 
Carrageenan –induced paw oedema is the most commonly used method in experimental 
pharmacology. Carrageenan is a sulphated polysaccharide obtained from sea weed 
(rhodophyceae), and by causing the release of histamine, 5-HT, bradykinin and 
prostaglandins, it produces inflammation and oedema 
[49, 50]
. 
Procedure 
The rats were divided into four groups containing six rats in each group. 0.1 ml 
of 1.0% carrageenan in normal saline (0.9% w/v NaCl) was injected to the sub plantar 
region of right hind paw. The trial drug was administered to the rats 1 h before 
carrageenan injection. Different groups were treated as follows: 
Group I: Carrageenan (0.1 ml of 1.0% carrageenan/rat to the sub plantar region).  
Group II: Carrageenan + Indomethacin (10 mg/kg b. w., p. o.) 
Group II and IV: Carrageenan + trial drug (100 mg/kg and 200 mg/kg b. w., p. 
o.respetcively).  
The paw volume was measured initially and at 1, 2, 3 and 4 h after carrageenan 
injection, using Plethysmograph, inflammation was calculated for comparison. 
B) Dextran induced rat paw oedema 
The rats were divided into four groups containing six rats in each group. 0.1 ml 
of 1.0% dextran in normal saline (0.9% w/v NaCl) was injected to the sub plantar region 
of right hind paw
 [51]
. The trial drug was administered to the rats 1 h before dextran 
injection. Different groups were treated as follows: 
Group I: Dextran (0.1 ml of 1.0% dextran/rat to the sub plantar region). 
Group II: Dextran + Indomethacin (10 mg/kg b. w., p. o.) 
Group III and IV: Dextran +trial drug (100 mg/kg and 200 mg/kg b.w., 
p.o.respetcively).  
The paw volume was measured initially and at 1, 2, 3 and 4 h after dextran 
injection, using Plethysmograph,inflammation was calculated for comparison
[52,53] 
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.C) Histamine induced rat paw oedema 
The rats were divided into four groups containing six rats in each group. 0.1 ml 
of 1.0% histamine sulphate in normal saline (0.9% w/v NaCl) was injected to the sub 
plantar region of right hind paw. The test drug was administered to the rats 1 h before 
histamine injection. Different groups were treated as follows: 
Group I: Histamine (0.1 ml of 1.0% histamine/rat to the sub plantar region). 
Group II: Histamine + Indomethacin (10mg/kg b. w., p. o.) 
Group III and IV: Histamine + trial drug (100 mg/kg and 200 mg/kg b.w., p.o. 
respectively).  
The paw volume was measured initially and at 1, 2, 3 and 4 h after histamine 
injection, using Plethysmograph, inflammation was calculated for comparison
 [54, 55]
 
ANTI RHEUMATIC ACTIVITY 
Collagen-induced arthritis (CIA) 
 The CIA model in rats is induced by intradermal injections of 
heterologous type II collagen in IFA, followed by a booster injection on 
day 7.  
 Heterologous type II collagen is highly arthritogenic in DA, BB-DR and 
LEW, but not in BN or F344, strains of inbred rats. Homologous rat type 
II collagen is also arthritogenic in DA but not in other rat strains.
[56]
 
  Erosive polyarthritis typically develops 10-14 days after the primary 
immunization.  
 Auto reactive T cells, as well as B cells, which produce antibodies to 
type II collagen, play a critical role in disease progression.  
 Similar to RA, females tend to be more susceptible than males, and 
arthritic rats also produce rheumatoid factor and antibodies against heat 
shock protein Hsp65
[57,58,59]
 
 
 
REVIEW OF LITERATURE  
 
         Anti-Rheumatic Activity of Keelvayu Nivarana Chooranam 
61 
Adjuvant-induced arthritis (AIA) 
 Experimental arthritis was induced in rats according to method of 
Newbould. 
 The right footpad of each rat was injected subcutaneously with 0.1 ml of 
Freund‘s Complete Adjuvant agent (FCA, sigma).  
 The extract at three dose levels (100, 200 mg/Kg.i.p), distilled water and 
Acetyl salicylic acid (ASA) at 10mg/Kg were given daily for 16 
consecutive days to the treatment groups, control group and reference 
group respectively.  
 Treatment started from day 8th after FCA injection.  
 The assessment of theantiarthritic activity was done by measuring the 
mean paw edema on the 8th, 12, 16 and 24 days post injection of 
FCA
[60,61]
 
Formalin –induced Arthritis 
 The test was performed according to Dubuissson and Dennis . 
 The extract was dissolved in a mixture of propylene glycol and water 
(1:4). 
 The extracts (100, 200 mg/Kg) and ASA (10mg/Kg.) were administered 
i.p in a volume of 1.5-2ml. 
 Control group received only vehicle (1.5-2ml) Briefly 30 min after 
treatment, 50 μl (2.5% v/v in distilled water) of formaldehyde was 
injected subcutaneously into the plantar surface of the hind paw of rats.  
 The behavioral responses to nociception were noted and the time spent 
licking, biting or scratching the injected hind paw was recorded up to 
30min. 
 The first 5 min was considered as early phase (neurogenic phase) and the 
period of 15-30 min as late phase (inflammatory phase). 
Agar- induced edema of the rat paw 
 The rat paw edema method was used, whereby agar is the edematogenic 
agent.  
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 Acute inflammation was measured in terms of change in volume of the 
rat hind paw induced by subplantar injection of agar.  
 Animals (n =5 group) received 100, 200mg/Kg of MFB administrated 
orally.  
 Edema was induced one hour later with agar (0.1ml) injected into the sub 
plantar region of the right hind paw of the rats.  
 The volume of distilled water displaced by the treated paw was measured 
before and 1,2,3 and 4 hr after induction of edema using a 
plethysmometer (model 7159, Ugo Basile, Varese ,Italy).  
 Control groups received either equivalent volume of the vehicle (distilled 
water) or indomethacin (100mg/Kg).  
 Inflammation was assessed as the difference between the zero time 
volume of the treated paw (Vo) and the volume at the various times (Vt) 
after the administration of the phlogistic agent.  
 Percent inhibition of edema Inhibition of edema (%) = 100 [1-{(a-x)/ (b-
y)}].  
 Where a= mean paw volume of treated rats at various time after agar 
injection, x = mean paw volume of treated rats before agar injection, 
b=mean paw volume of control rats at various time after agar, y = mean 
paw volume of control rats before agar injection. 
3.5 LATERAL RESEARCH 
Hemidesmus indicus: 
[62] 
 Administration of aqueous extract of Hemidesmus indicus roots 
(500mg/kg/day) for a period of 12 weeks decreased lipid peroxidation 
index which is attributed to its antioxidant action.  
 Ethanolic extract of Hemidesmus indicus has protective effect against 
ethanol induced liver injury (hepato protective). H. indicus extract 
significantly decreased level of liver collagen and hydroxyproline 
content, lipid peroxidation and increases solubility of liver collagen and 
ascorbic acid level. 
 95% ethanolic extracts of roots of H. indicus possess antifungal activity 
against Aspergillus niger.  
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 Hemidesmus indicus extract inhibited tumor growth in mouse skin and 
hence can be considered as a potent chemopreventive agent (anti-
carcinogenic activity). 
Smilax chinensis: 
 The ethyl acetate, butanol and aqueous extracted fractions from S. china 
root showed high levels of DPPH free radical scavenging activity( anti-
oxidant). 
[63]
 
 Experimental studies reveals that the aqueous and alcoholic extracts from 
Smilax china roots (200 mg/kg) orally administered for 7 days produced 
a significant decrease in the blood glucose level in the model of alloxan-
induced diabetes in rats (anti-diabetic activity). 
[64]
 
 Smilax chinensis L. extract in affording the hepatoprotective activity 
against carbon tetrachloride may be due to the cell membrane 
stabilization and hepatic cell regeneration. 
[65]
 
Withania somnifera: 
[66] 
 W. somnifera is known to alter the oxidative stress markers of the body. 
The root extract has found to significantly reduce the lipid peroxidation 
and increase the superoxide dismutase (SOD) and catalase activities, thus 
carrying free radical scavenging property. 
 It is been proved to have hepatoprotective effect against radiation 
induced and iron induced toxicity Withania somnifera helped in 
decreasing the significantly altered levels of Bilirubin thus bringing liver 
to function normally. Withaferin A at 10mg/kg dose showed 
significantly protective effect against CCl4-induced hepatotoxicity in 
rats. 
 Withaferin A, withanolide D & E exhibited significant antitumour 
activity in vitro against cells derived from human epidermoid carcinoma 
of nasopharynx (KB) and in vivo against Ehrlich ascites carcinoma, 
Sarcoma 180, Sarcoma Black (SBL), and E 0771 mammary 
adenocarcinoma in mice. 
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Alpinia officinarum 
 Anti-oxidant activity 
 Radical scavenging activities of galanga extracts were performed 
by 2, 2-diphenyl-1-picrylhydrazyl (DPPH) and 2, 2‘-azino-bis (3-
ethylbenzothiazoline-6-sulphonic acid) radical scavenging assays. This 
study clearly showed that galanga had marked antioxidant, 
anticholinergic effect, reducing ability, radical scavenging and metal 
binding activities. 
[67]
 
 Anticholinergic activity 
Inhibition effects of galanga extracts on AChE activities were 
measured. AChI, and DTNB (Product no: D8130-1G, Sigma–Aldrich) 
were used for the determination of the AChE activity. Namely, 100 ml of 
buffer (Tris/HCl, 1 M, pH 8.0), 10 mL of sample solution dis-solved in 
deionised water at different concentrations.
 [67-a]
 
 Expectorant activity  
It was studied on rabbits partially anaesthetised with intravenous 
injection of urethane. 
[68]
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 4. MATERIALS AND METHODS 
4.1. DRUG SELECTION  
In this dissertation the Keelvayu Nivarana Chooranam was taken as a 
compound drug for Rheumatoid arthritis from the literature The Pharmacopoeia of 
Siddha Research Medicine (chapter 2-14) written by Dr. M. Shanmugavelu & 
Dr.G.D.Naidu. Published by: G.D.Naidu Charities, 84, President hall, Coimbatore-18. 
Page no: 118  
Ingredients 
1. Nannariverpattai Chooranam  (Hemidesmus indicus)     - 116 g 
2. Parangipattai Chooranam        (Smilax chinensis)          - 116 g  
3. Seemai Amukara Chooranam  (Withania somnifera)      - 116 g 
4. Chittaraththai Chooranam      (Alpinia officinarum)      -  58 g 
 
Source of Collection 
All the raw drugs were bought from Ramasamy chetty country drug shop at 
Parry’s corner, Chennai, Tamilnadu, India. 
Identification and Authentication of the drug  
All the raw drugs were identified and authenticated by the Gunapadam experts 
in Government Siddha Medical College, Arumbakkam, Chennai – 106. The specimen 
sample of all the herbs have been preserved in PG Gunapadam department individually 
for future reference. 
                                  Ref No: GSMC/PGGM/014-017/2014-2017 
Purification of the drugs 
 All the drugs mentioned here were purified as per the Siddha literature. 
 Nannariverpattai were washed in the running tap water to remove the soil and 
impurities. 
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 Parangipattai was dried and powdered and then it was purified by Pittaviyal 
method (steam cooking in milk). A mud pot was taken and it was half filled by 
milk and half filled by pure water. The mouth of the pot was sealed by a cloth. 
This chooranam then placed over the cloth and the pot was heated.  The same 
drug was later dried and powdered then sieved again. 
 Amukara was dried and powdered and then it was purified by Pittaviyal method 
(steam cooking in milk). A mud pot was taken and it was half filled by milk and 
half filled by pure water. The mouth of the pot was sealed by a cloth. This 
chooranam then placed over the cloth and the pot was heated.  The same drug 
was later dried and powdered then sieved again. 
 Chittaraththai were washed in the running tap water to remove the soil and 
impurities. 
 
Preparation of the trial drug – Keelvayu Nivarana Chooranam 
Procedure 
All the above purified ingredients were powdered in an iron mortar separately 
and it was sieved by a cotton cloth. Then these powders were mixed together and 
bottled up. It was labeled as Keelvayu Nivarana Chooranam (KVNC). 
Purification of the Chooranam: Steaming process (Pittaviyal murai) 
The Keelvayu Nivarana Chooranam was purified by pittaviyal method (steam 
cooking in milk) as per Siddha classical literature. A mud pot was taken and it was half 
filled by milk and half filled by pure water. The mouth of the pot was sealed by a cloth. 
This chooranam then placed over the cloth and the pot was heated. After this process the 
drug was later dried and powdered then sieved again. It was used for the further study.  
Storage of the drug 
The prepared test drug was stored in a clean, air tight glass container. The 
contents were inspected frequently to avoid moisture and insects. 
Administration of the drug 
Form of the medicine  : Chooranam 
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 Route of Administration : Enteral 
 Dose    : 1g twice a day  
 Anubanam    : Honey 
4.2. STANDARDIZATION OF KEELVAYU NIVARANA CHOORANAM BY 
USING MODERN TECHNIQUES 
 Standardization of drug helps to authenticate and determine its quality and 
efficiency. Standardization of herbal drug is rooted in qualitative and quantitative 
analysis by means of Physico chemical properties and instrumental analysis.   
The Physico-chemical analysis of Keelvayu Nivarana Chooranam was done.  
The chemical finger print was engaged by using modern analytical technique 
FTIR (Fourier Transform Infra-Red Spectroscopy). 
The particle size and qualitative analysis of chemical elements of Keelvayu 
Nivarana Chooranam were also assessed by Scanning Electron Microscope (SEM).  
The quantitative and qualitative analysis of chemical elements was carried out 
by using inductively   X-Ray Fluorescence Spectroscopy (XRF). 
ORGANOLEPTIC CHARACTERS 
 The organoleptic characters of the sample drug were evaluated. 1gm of the 
KVNC was taken and the colour, texture, particle size and other morphological 
characters were viewed by naked eye under natural light. Then the result is tabulated in 
Table No: 5 
4.2.1. PHYSICO-CHEMICAL ANALYSIS  
Quantitative analysis 
Total Ash 
3gm is accurately weighed and incinerated in a crucible dish at a temperature not 
exceed 450oC until free from carbon. It is then cooled and weighed. The % w/w of ash 
with reference to the air-dried powder is calculated
 [69]
. 
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Water Soluble Ash 
The total ash is obtained as the above method for preparation of total ash. The 
ash is boiled for 5 minutes with 25ml water. The insoluble ashes is collected using filter 
paper and washed with hot water and then transferred to the silica crucible then ignite 
for 15 minutes at temperature not exceeding 450
o
C. The silica crucible and residue are 
weighed until constant weight is attained for determination of weight of insoluble ash. 
The weight of the water soluble ash was determined by subtracting the weight of 
insoluble ash from the weight of total ash. 
Acid insoluble Ash 
The total ash was obtained as the above method for preparation of total ash. The 
ash was boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes was collected 
using filter paper and washed with hot water and then transferred to the silica crucible 
then ignite for 15 minutes at temperature not exceeding 450oC. The silica crucible and 
residue are weighed until constant weight is attained. 
Determination of Extractive value 
Alcohol Soluble Extractive Value 
3g of KVNC was weighed and macerated with 100ml of ethanol in a closed 
container for 24 hours. The resulting solution was shaken continuously for 6 hours. It 
was then allowed to stand and soak for 18 hours. The solution was filtered and 
evaporated of the filtrate in a flat bottomed shallow dish and dried at 105
o
C. Then the 
content was cooled and weighed. 
Water soluble Extractive value  
3g of KVNC was weighed and macerated with chloroform and water, 
respectively, at 80
o
C for 24 hrs. The resulting solution was shaken continuously for 6 
hours and allowed to stand and soak for 24hrs then filtered. The solution from both 
chloroform and water respectively was filtered and evaporated of the filtrate in a flat 
bottomed shallow dish. It was dried at 105
o
C then cooled and weighed. 
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Loss on Drying 
The powdered drug is dried in the oven at 100- 105°C to constant weight. 
Physical Characterization 
Solubility 
a. A little of the sample was shaken well with distilled water.  
b. A little of the sample was shaken well with con Hcl and Con H2SO4. 
Sparingly soluble character indicates the presence of Silicate. 
pH value 
Potentiometrically pH value determined by a glass electrode and a suitable pH 
meter.  
Action on heat  
A small amount of the sample was taken in a dry test tube and heated gently. If 
strong white fumes evolve indicate the presence of Carbonate. 
Flame test 
A small amount of the sample was made into a paste with con.Hcl in a watch 
glass and introduced into non-luminous part of the Bunsen flame. Appearance of bluish 
green flame indicates the presence of Copper. 
Ash Test 
A filter paper was soaked into a mixture of sample and cobalt nitrate solution 
and introduced into the Bunsen flame and ignited. Appearance of yellow colour flame 
indicates the presence of Sodium
 [70]
. 
All the results were noted and tabulated in Table No: 6 
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4.2.2 PHYTOCHEMICAL ANALYSIS 
The Phytochemical screening of the extract gives general idea regarding the 
nature of chemical constituents present in the crude drug. The phytochemical tests were 
done as the method illustrated in Prashant Tiwari et al., 2011 and Harborne, 1973. 
Test for Alkaloids 
A small portion of solvent free extracts were stirred separately with few drops of 
dilute hydrochloric acid and filtered & tested carefully with various alkaloidal reagents. 
Mayer’s reagent   - Cream precipitate 
Dragendroff’s reagent  - Orange brown precipitate 
Hager’s reagent   - Yellow precipitate 
Wagner’s reagent   - Reddish brown precipitate 
Test for Carbohydrates and Reducing Sugars 
The minimum amount of extracts were dissolved in 5ml of distilled water & 
filtered. The filtrate was subjected to test for carbohydrates & glycosides. 
a) Molisch’s test 
The filtrate 1 ml was treated with 2-3 drops of 1% alcoholic alpha naphthol & 
2ml concentrated sulphuric acid was added along the sides of test tube. Violet ring was 
observed at the junction of 2 layers which showed the presence of carbohydrate. 
b) Benedict’s test 
The filtrate 1 ml was treated with Benedict’s reagent and heated gently. Orange 
red precipitate indicates the presence of reducing sugars. 
c) Fehling’s test 
The filtrate 1 ml was treated with equal volume of Fehling’s solution A and B 
and heated gently. Orange red precipitate indicates the presence of reducing sugars. 
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Test for Glycosides 
The extract was hydrolyzed with dil. HCl and subjected to test for glycosides. 
a) Modified Borntrager’s test 
To the hydrolysate extract, 1 ml of Ferric chloride solution was added and 
immersed in boiling water for about 5 min. The mixture was cooled and extracted with 
equal voulme of benzene. The benzene layer was separated and treated with ammonia 
solution. Formation of rose pink colour in the ammoniacal layer indicates the presence 
of Anthranol glycosides.  
b) Legal’s test 
The hydrolysate extract was treated with Sodium nitropruside in pyridine and 
sodium hydroxide. Formation of pink to blood red colour indicates the presence of 
Cardiac glycosides.  
Test for Saponins 
The extract 0.5 ml was shaken with 5 ml distilled water. The presence of 
saponins was indicated by formation of copious lather. 
Test for Tannins 
Gelatin test 
To the extract, 1% gelatin solution containing sodium chloride was added. 
Formation of white precipitate indicates the presence of tannins. 
Test for Phenolic compounds 
To 0.5 ml of extract, 1 ml of alcoholic ferric chloride solution was added. 
Formation of bluish green or bluish black indicates the presence of Phenolic 
compounds. 
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Test for Phytosterol 
Ferric chloride – acetic acid test 
1 ml of extract was treated with 1 ml of chloroform and then, 2 ml of ferric 
chloride acetic acid reagent was added followed by 1 ml of conc. sulphuric acid. 
Appearance of reddish pink colour shows the presence of phytosterol. 
Test for Diterpenes 
Copper acetate test 
1 ml of extract was dissolved in water and treated with 3-4 drops of Copper 
acetate solution. Formation of emerald green colour indicates the presence of 
diterpenes. 
Test for Triterpenes 
Salkowski’s test 
1 ml of extract was treated with 1 ml of chloroform followed by 1 ml of conc. 
sulphuric acid, shaken and allowed to stand. Appearance of golden yellow colour shows 
the presence of triterpenes. 
Test for Flavonoids 
a) Alkaline reagent test 
To 1 ml of extract, 1 ml of 10% sodium hydroxide solution was added. 
Formation of dark yellow colour indicates the presence of flavonoids. 
b) Lead acetate test 
To 1 ml of extract, 3-4 drops of 10% lead acetate solution was added. Formation 
of yellow precipitate indicates the presence of flavonoids. 
c) Ferric chloride test 
To 1 ml of extract, 3-4 drops of ferric chloride solution was added. Formation of 
dark green colour indicates the presence of flavonoids. 
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d) Shinoda test 
To 1 ml of extract, few mg of magnesium turnings was added followed by few 
drops of conc. hydrochloric acid and boiled for five minutes in a boiling water bath. 
Formation of red colour indicates the presence of flavonoids. 
Test for Proteins and Free Amino Acids 
a) Xanthoproteic test 
To 1 ml of extract, 3-4 drops of conc. nitric acid was added. Formation of 
yellow precipitate indicates the presence of proteins. 
b) Million’s test  
To 0.5 ml of extract, 2.5 ml of Million’s reagent was added. Formation of white 
precipitate and the precipitate warmed indicates the presence of proteins. 
c) Biuret test  
 To 0.5 ml of extract, 2.5 ml of diluted Biuret reagent was added.  Appearance of 
purple colour or brick red precipitate showed the presence of proteins and free amino 
acids. 
Test for Quinones 
Sodium hydroxide test 
To 0.5 ml of extract, 1 ml of 10% sodium hydroxide was added.  Appearance of 
blue or green or red colour shows the presence of quinones. 
Results of phytochemical analysis were noted and tabulated in Table No: 7 
4.2.3. TLC/HPTLC FINGER PRINT STUDIES  
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of cooled 
concentrated sulphuric acid. Ice was added and stirred well. The solution was stored 
in refrigerator.   
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Chromatographic conditions  
Instrumen    :  CAMAG (Switzerland). 
Sample applicator   :  Camag Linomat - IV applicator with N2 gas flow                                                             
Photo documentation System  :  Digi store - 2 documentation system with Win 
                                                               Cat and video scan software. 
Scanner    :  Camag HPTLC scanner - 3 (030618), Win Cats - 
IV. Development Chamber   : Camag HPTLC 10X10, 10 X 20 twin trough     
                                                               linear development chamber. 
Quantity applied          :  5, 10 µl for extracts and 5 µl for standards 
Stationary phase          : Aluminium plate pre-coated with silica gel 60(E. 
                                                                Merck) 
Plate thickness         :  0.2 mm. 
Mobile Phase    : For Chloroform extract - Toluene: Ethyl acetate          
          (9:1) Ethanol extract - Toluene: Ethyl acetate 
         (1:1).   
Scanning wavelength              : 254 nm 
Laboratory condition              : 26 ± 5
o
C and 53 % relative humidity 
    The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using 
vanillin-sulphuric acid reagent heated at 105° till colour spots appeared.  
. 
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Retention Factor 
After a separation is complete, individual compounds appear as spots separated 
vertically. Each spot has a retention factor (Rf) which is equal to the distance migrated 
over the total distance covered by the solvent.  
The Rf formula is Rf  = distance traveled by sample /distance traveled by solvent 
The Rf value can be used to identify compounds due to their uniqueness to each 
compound.  When comparing two different compounds under the same conditions. 
The compound with the larger Rf value is less polar because it does not stick to 
the stationary phase as long as the polar compound, which would have a lower Rf value. 
Method 
Extract  4  g  of sample  in alcohol  (25  ml  x  3)  under  reflux  on  a  water-bath  
for  30  min, filter,  concentrate  to  10  ml  and  carry  out  the  thin  layer  
chromatography.   
Apply 10 µl of the extract on TLC silica gel precoated Aluminium plate and 
develop the plate to a distance of 8 cm using toluene: ethyl acetate (5:  3) as mobile 
phase. After development allow the plate to dry in air and examine under ultraviolet 
(254 nm & 366 nm). 
HPLTC results were noted and tabulated in Table No: 8 
 4.2.4. BIO-CHEMICAL ANALYSIS 
[71] 
Methodology for chemical analysis 
Preparation of extract 
 5gm of KVNC was weighed accurately and placed in a 250ml clean 
beaker and added with 50ml of distilled water.  
 Then it was boiled well for about 20 minutes.  
 Then it was cooled and filtered in a 1000ml volumetric flask and made 
up to 100ml distilled water. 
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                                   Table No.2. Test for basic radicals 
PROCEDURE OBSERVATION INFERENCE 
Test for Potassium:  
      A pinch of sample is treated with 2ml of 
sodium nitrate solution and then treated with 
2ml of cobalt nitrate in 30% of glacial acetic 
acid. 
 
Formation of Yellow 
colour precipitate 
 
Presence of 
Potassium 
Test for Calcium:  
       Taken 2 ml of extract in a clean test tube. 
Then acetic acid and potassium 
chromate solution were added 
 
No Yellow precipitate 
 
Presence of 
Calcium 
Test for Magnesium: 
      2ml of extract was taken in a clean test 
tube, few drops of Magnason reagent was 
added in drops. 
 
Formation of Blue  
colour precipitate 
 
Presence  of 
Magnesium 
Test For Ammonium: 
     2ml of extract was taken in a test tube and 
added few ml of Nessler's reagent.  
 
Appearance of Brown 
colour 
 
 
Presence of 
Ammonium 
Test For Sodium: 
    2 pinches of Keelvayu Nivarana Chooranam 
was mixed with HCl and made it into paste.  
And introduced into the blue flame of Bunsen 
burner. 
 
 
Appearance of intense 
Yellow colour 
 
 
 
Presence of 
Sodium 
Test for Iron (Ferrous):   
    2ml of extract was taken in a clean dried test 
tube and conc. HNO3 and ammonium 
thiocyanate were added. 
 
Appearance of Blood 
red colour 
 
Presence of 
Ferrous iron 
Test For Zinc: 
   2 ml of the extract was taken in a test tube 
and Potassium ferro cyanide solution was 
added.  
  
 
Formation of White 
colour precipitate 
 
Presence  of 
Zinc 
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                           Results were noted and tabulated in Table No: 10 
 
 
 
 
 
 
PROCEDURE OBSERVATION INFERENCE 
Test For Aluminium: 
    To the 2m1of the extract was taken in a test 
tube sodium hydroxide drops were added to it. 
 
 
White precipitate 
obtained 
 
Presence of 
Aluminium 
Test For Lead: 
    2 ml of extract was taken in a test tube and 
added with 2ml of potassium iodide solution 
 
 
 
Formation of yellow 
colour precipitate 
 
Presence of 
Lead 
Test for Copper: 
    To a small portion of a extract dilute 
hydrochloric acid was added and then 
hydrogen sulphide gas is passed through the 
solution. 
 
Black precipitate 
 
Presence of 
Copper 
 
Test For Mercury: 
2m1 of the extract was taken in a test tube and 
treated With 2ml of sodium hydroxide 
solution. 
Formation of Yellow 
precipitate 
 
Presence of 
Mercury 
 
 
Test for Arsenic:       
2m1 of the extract was taken in a test tube and 
treated with 2ml of sodium hydroxide solution. 
Formation of 
brownish red 
precipitate 
Presence of 
Arsenic 
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Table No.3. Test for acidic radical 
                               Results were noted and tabulated in Table No: 11 
 
 
 
PROCEDURE OBSERVATION INFERENCE 
Test for Sulphate: 2 ml of the extract was 
taken in clean, dry test tube and 5 % 
barium chloride solution was added to it. 
Formation of white 
precipitate 
Presence of 
Sulphate 
Test for Chloride: The extract was taken 
in a test tube and then treated with Silver 
nitrate solution. 
Formation of White 
precipitate 
Presence of 
Chloride 
Test for Phosphate: The extract was 
taken in a test tube and treated with 
ammonium molybdate and conc. HNO3. 
Formation of Yellow 
precipitate 
Presence of 
Phosphate 
Test for Carbonate: The substance was 
taken in a clean dry test tube and then 
treated with Conc. HCl. 
Formation of 
Effervescence 
Presence of 
Carbonate 
Test for fluoride &oxalate: 2ml of 
extract was taken in a test tube and added 
with 2ml of dil.acetic acid, 2ml calcium 
chloride solution and then heated. 
Formation of cloudy 
appearance 
Presence of 
Fluoride & 
Oxalate 
Test For Nitrate: 1gm of the KVNC was 
heated with copper turnings and 
concentrated H2SO4 and observed the test 
tube vertically down. 
Characteristic changes Presence of 
Nitrate 
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                                                  4.2.5. MICROBIAL LOAD 
Enumeration of bacteria by plate count – agar plating technique 
The plate count technique was one of the most routinely used procedures 
because of the enumeration of viable cells by this method. 
Principle 
This method is based on the principle that when material containing bacteria are 
cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies therefore is the same as the number of organisms 
contained in the sample. 
Dilution 
A small measured volume is mixed with a large volume of sterile water or saline 
called the diluent or dilution blank. Dilution is usually made in multiples of ten. 
A single dilution was calculated as follows: 
            Volume of the sample 
                                             Total volume of the sample and the diluent 
Requirements 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter. 
Procedure 
 Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
 Prepare the initial dilution by adding 1 ml of the sample into a 9 ml 
dilution blank labeled 10
-1
 thus diluting the original sample 10 times. 
 Mix the contents by rolling the tube back and forth between hands to 
obtain uniform distribution of organisms. 
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 From the first dilution transfer 1 ml of the suspension while in motion, to 
the dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the 
original specimen to 100 times. 
  From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution 
blank with a fresh sterile pipette, thus diluting the original sample to 100 
times. 
 Repeat this procedure till the original sample has been diluted 
10,000,000 times using every time a fresh sterile pipette. 
 From the appropriate dilutions transfer 1ml of suspension while in 
motion, with the respective pipettes, to sterile petri dishes. Three petri 
dishes are to use for each dilution. 
 Add approximately 15 ml of the nutrient medium, melted and cooled to 
450c, to each petri dish containing the diluted sample. Mix the contents 
of each dish by rotating gently to distribute the cells throughout the 
medium. 
 Allow the plates to solidity. 
 Incubate these plates in an inverted position for 24-48 hours at 370c. 
Observation 
Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates. 
Calculate the number of bacteria per ml of the original suspension as follows: 
   Number of colonies (average of 3 replates) 
                                                            Amount of plated × dilution 
          Results were noted and tabulated in Table No: 12 
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4.2.6. INSTRUMENTAL ANALYSIS 
FTIR analysis 
Principle 
FTIR microscopy is the conjunction of optical microscopy with IR spectroscopy. 
IR is dedicated to identify the chemical composition of samples on the basis of 
functional groups of molecules. The knowledge of these characteristic frequencies of 
peaks allows us to perform bio-chemical analysis of a sample. The FTIR determines the 
differences in the chemical composition between samples
 [72]
.  
Infrared spectrum was useful in identifying the functional groups like -OH, -CN, 
-CO, -CH, -NH2, etc. FTIR spectrum is the most reliable method of reflecting the 
chemical constituents present in a complex system for validating herbal medicines.  
   
 
 
                    Fig.No.4. Showing the picture of FTIR mechanism 
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Instrument details 
Model   :  Spectrum one: FT-IR Spectrometer  
Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid 
Procedure 
KBr Pellet procedure  
About 1/8
th
 of the solid KVNC was taken on a microspatula and about 0.25-0.50 
teaspoons of KBr was added and thoroughly ground in a mortar with the pestle until it 
became very fine. It was placed in a pellet die.  
The sample was pressed at 5000-10,000 psi and the sample was removed 
carefully from the die and placed in the FTIR sample holder.  
The computer was turned on and the software was launched and certain fine 
details of the working method were done. The sample was placed on ZnSe crystal with 
a spatula until the pressure marker showed 12. The computer display showed spectrum 
of graphs with peaks and the results were printed.  
                          Results were noted and tabulated in Table No: 13 
XRD (X-RAY POWDER DIFFRACTION) 
Definition 
X-ray powder diffraction is most widely used for the identification of unknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
Applications 
 Characterization of crystalline materials [73] 
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 Identification of fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically 
 Determination of unit cell dimensions. 
With specialized techniques, XRD can be used to: 
 Determine crystal structures using Rietveld refinement 
 Determine of modal amounts of minerals (quantitative analysis) 
 Characterize thin films samples by: 
 determining lattice mismatch between film and substrate and to 
inferring stress and strain 
 determining dislocation density and quality of the film by rocking 
curve measurements 
 measuring super lattices in multilayered epitaxial structures 
 determining the thickness, roughness and density of the film using 
glancing incidence X-ray reflectivity measurements 
 Make textural measurements, such as the orientation of grains, in a 
polycrystalline sample. 
                                        
 
                         Fig No.5.  Showing the picture of XRD Mechanism 
 
MATERIALS AND METHODS  
 
Anti – rheumatic activity of keelavayu nivarana chooranam 
84 
Strengths and Limitations of X-ray Powder Diffraction 
Strengths 
 Powerful and rapid (< 20 min) technique for identification of an 
unknown mineral 
 In most cases, it provides an unambiguous mineral determination 
 Minimal sample preparation is required 
 XRD units are widely available 
 Data interpretation is relatively straight forward. 
Limitations 
 Homogeneous and single phase material is best for identification of 
unknown 
 Must have access to a standard reference file of inorganic compounds 
 Requires tenths of a gram of material which must be ground into a 
powder 
 For mixed materials, detection limit is ~ 2% of sample 
 For unit cell determinations, indexing of patterns for non-isometric 
crystal systems is complicated. 
Sample Collection and Preparation 
Determination of an unknown requires: the material, an instrument for grinding, 
and a sample holder. 
 Obtain a few tenths of a gram (or more) of the material, as pure as 
possible 
 Grind the sample to a fine powder, typically in a fluid to minimize 
inducing extra strain (surface energy) that can offset peak positions, and 
to randomize orientation.  
 Powder less than ~10 μm(or 200-mesh) in size is preferred place into a 
sample holder or onto the sample surface. 
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SEM (SCANNING ELECTRON MICROSCOPE) 
[74] 
 In scanning electron microscope high-energy electron beam is focused through a 
probe towards the sample material. Variety of signals was produced on interaction with 
the surface of the sample. This results in the emission of electrons or photons and it is 
collected by an appropriate detector.  
The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample. 
Instrument details 
Model   : SEM-Hitachi 
Scan Range   : S-3400n 
Resolution   : 1.2 nm gold particle separation on a carbon substrate 
Magnification  : From a min of 12 x to greater than 1, 00,000 X 
Procedure 
 The study was conducted in a very fine powder of the drug and the 
sample was quick frozen in liquid nitrogen.  
 The sample was mounted rigidly on a specimen holder called specimen 
stub.  
 The mounted sample was placed inside the microscope’s vacuum column 
evaporator through an air tight door. 
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 On expelling air from the air pump, a beam of electrons passed from an 
electron gun. This beam travelled through a series of magnetic lenses 
designed to focus the electrons.  
 The focused beam moved back across the mounted sample row by row by 
a set of scanning coils.  
 As the electron beam hit each spot on the sample, secondary electrons are 
backscattered from its surface.  
 A detector counts these electrons and sends the signals to an amplifier. 
The final image was built up from the no of electrons emitted from each 
spot on the sample.  
 The micrographs obtained give sufficient data about the topography of the 
subjected sample. 
 
                             Fig. No.6. Showing schematic diagramme of SEM 
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ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
[75] 
Manufacturer: Perkin Elmer 
Model: Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle 
An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) in different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights).  
 
                 
                             Fig. No.7.  Showing schematic diagramme of ICPOES 
These releases are separated based on their respective wavelengths and their 
strengths are measured (spectrometry). The intensities are proportional to the 
concentrations of analyses in the aqueous sample.  
The quantification is an external multipoint linear standardization by comparing 
the emission intensity of an unknown sample with that of a standard sample.  
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Multi-element calibration standard solutions are prepared from single- and multi 
element primary standard solutions. With respect to other kinds of analysis where 
chemical speciation is relevant (such as the concentration of ferrous iron or Ferric Iron), 
only total essential concentration is analysed by ICP-OES. 
Application 
The analysis of major and minor elements in solution samples. 
Objectives 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 Probes the outer electronic structure of atoms. 
Mechanism 
In plasma emission spectroscopy (OES), a sample solution is presented into the 
core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C.  
At this temperature all elements become thermally excited and emit light at their 
characteristic wavelengths.  
This light is collected by the spectrometer and passes through a diffraction 
grating that serves to resolve the light into a spectrum of its essential wavelengths.  
Within the spectrometer, this deflected light is then collected by wavelength and 
amplified to yield strength of measurement that can be converted to an elemental 
concentration by comparison with standardization values. 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, Chennai-36 using Perkin Elmer Optima 
5300 DV. 
 Results were noted and tabulated in Table No:14 
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  4.3. TOXICOLOGICAL STUDIES 
                    4.3.1. Acute Oral Toxicity Study (OECD Guideline – 423) [76] 
Introduction 
 The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity of 
the test substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
 The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification 
purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
Principle of the Test  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step; sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
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orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. 
Absence or presence of compound-related mortality of the animals dosed at one step 
will determine the next step, i.e. 
− No further testing is needed 
− dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance 
to one of a series of toxicity classes. 
Methodology 
Selection of Animal Species  
 The preferred rodent species is the wistar albino rat, although other rodent 
species may be used. Healthy young adult animals are commonly used laboratory 
strains should be employed. Females should be nulliparous and non-pregnant. Each 
animal, at the commencement of its dosing, should be between 6 to 8 weeks old and the 
weight (150-200gm) should fall in an interval within±20 % of the mean weight of any 
previously dosed animals.  
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hours light, 12 hours dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals may 
be group-caged by dose, but the number of animals per cage must not interfere with 
clear observations of each animal. 
Preparation of animals 
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
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Test Animals and Test Conditions  
 Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
TANUVAS, Madhavaram, and Chennai. All the animals were kept under standard 
environmental condition (22±3 ° C).  The animals had free access to water and standard 
pellet diet (Sai meera foods, Bangalore). 
Preparation of animals 
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
Preparation for Acute Toxicity Studies 
 Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of Keelvayu Nivarana Chooranam. The principles of laboratory animal 
care were followed and the Institutional Animal Ethical Committee approved the use of 
the animals and the study design. 
                           IAEC No: IAEC/XLVIII/05/CLBMCP/2016 
Test Substance        :  Keelvayu Nivarana Chooranam 
Animal Source        :  Kings Institute, Chennai.   
Animals         :  Wister Albino Rats (Female-3+3) 
Age          :  >6 weeks 
Body Weight on Day 0     :  150-180 gm. 
Acclimatization       :  Seven days prior to dosing. 
Veterinary examination    :  Prior and at the end of the acclimatization period. 
Identification of animals   :    By cage number, animal number and individual    
                                                  marking by using Picric acid. 
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Number of animals  : 3 Female/group,  
Route of administration : Oral  
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,     
                                                  Bangalore. 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
                                                   provided with bedding of husk. 
Housing temperature             : between 22ºC + 3ºC.  
Relative humidity  : between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study             : 14 Days 
Administration of Doses  
 Keelvayu Nivarana Chooranam was suspended in water and administered to the 
groups of wistar albino rats in a single oral dose by gavage using a feeding needle. The 
control group received an equal volume of the vehicle.  
Animals were fasted 12 hours prior to dosing. Following the period of fasting, 
the animals were weighed and then the test substance was administered. Three Female 
animals are used for each group. The dose level of 20, 100 and 200 mg/kg body weight 
was administered stepwise.  
After the substance has been administered, food was withheld for a further 3-4 
hours. The principle of laboratory animal care was followed. Observations were made 
and recorded systematically and continuously as per the guideline after substance 
administration.  
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The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. Finally, the number of 
survivors was noted after 24 hrs and these animals were then monitored for a further 14 
days and observations made daily.  
The toxicological effect was assessed on the basis of mortality. 
Observations 
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead.  
It should be determined by the toxic reactions, time of onset and length of 
recovery period, and may thus be extended when considered necessary. The times at 
which signs of toxicity appear and disappear are important, especially if there is a 
tendency for toxic signs to be delayed.  
All observations are systematically recorded with individual records being 
maintained for each animal. 
Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma.  
The principles and criteria summarized in the Humane Endpoints Guidance 
Document taken into consideration. Animals found in a moribund condition and 
animals showing severe pain or enduring signs of severe distress was humanly killed.  
When animals are killed for human reasons or found dead, the time of death was 
recorded. 
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4.3.2. Repeated Dose 28-Day Oral Toxicity Study 
Test Substance  :  Keelvayu Nivarana Chooranam 
Animal Source  :  Kings institute, Chennai.   
Animals   :  Wister Albino Rats (Male -24, and Female-24) 
Age    :   >6 weeks 
Body Weight    :  160-180 gm. 
Acclimatization  :  Seven days prior to dose. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :  By cage number, animal number   and    individual  
    marking by using Picric acid 
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,       
       Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages 
                                                  provided with bedding of husk. 
Housing temperature             : between 22ºC + 3ºC.  
Relative humidity  : between 30% and 70%, 
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study    : 28 Days. 
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Table No.4. 28-days repeated oral toxicity study grouping 
Methodology 
Randomization, Numbering and Grouping of Animals 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consists of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three groups were treated with test drug (low, mid, high) for 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior to 
the initiation of treatment. Each animal was marked with picric acid. The females were 
nulliparous and non-pregnant. 
Justification for Dose Selection 
         As per OECD guideline three dose levels were selected for the study. They are 
low dose (20 mg/kg), mid dose (100 mg/kg), high dose (200 mg/kg). X is calculated by 
multiplying the therapeutic dose of human (1000mg/kg) and the body surface area of 
the rat (0.018). i.e X dose is 20 mg/kg/animal, 5X mid dose is 100 mg/kg, 10X high 
dose is 200 mg/kg. 
Preparation and Administration of Dose 
 Keelvayu Nivarana Chooranam suspended in with water, It was administered to 
animals at the dose levels of 20, 100 and 200 mg/kg. The test substance suspensions 
were freshly prepared every two days once for 28 days. The control animals were 
administered vehicle only. The drug was administered orally by using oral gavage once 
daily for 28 consecutive days. 
Groups No of Rats 
Group I     Vehicle control (Normal Saline ) 12(6male,6 female) 
Group II   Keelvayu Nivarana Chooranam 20 mg/kg 12 (6male,6 female) 
Group III   Keelvayu Nivarana Chooranam 100 mg/kg 12 (6male,6female) 
Group IV   Keelvayu Nivarana Chooranam 200 mg/kg 12(6male,6female) 
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Observations 
Experimental animals were kept under observation throughout the course of study 
for the following 
Body Weight 
  Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study. 
Food and water Consumption 
 Food and water consumed per animal was calculated for control and the treated 
dose groups.  
Clinical signs 
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality 
All animals were observed twice daily for mortality during entire course of 
study. 
Necropsy 
All the animals were sacrificed by excessive anaesthesia on day 29. Necropsy of 
all animals was carried out. 
Laboratory Investigations 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
Haematological Investigations 
Haematological parameters were determined using Haematology analyzer.  
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Biochemical Investigations 
Biochemical parameters were determined using auto-analyzer. 
Histopathology 
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low, then the mid dose group will also be examined. Organs will be collected 
from all animals and preserved in 10% buffered neutral formalin for 24 h and washed in 
running water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an 
auto technicon and then cleared in benzene to remove absolute alcohol. Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed 
by microtome and the slides were stained with Haematoxylin-eosin red. 
Statistical analysis  
Findings such as body weight changes, water and food consumption,hematology 
and blood chemistry were subjected to One-way ANOVA followed by dunnett test 
using a computer software programme – Graph pad  version 5.0 . 
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4.4. PHARMACOLOGICAL ANALYSIS 
4.4.1. Evaluation of Analgesic activity  
 Acetic acid induced writhing test 
           Wistar albino rats were divided into four groups (n = 6). Group I received acetic 
acid (1% v/v, 10 ml/kg b.w., i.p.) and writhing reflex was noted for the period of 15 
minutes. Group II received aspirin (100 mg/kg b.w.p.o.) 
 Group III and IV received KVNC at the doses of 100 mg/kg and 200 mg/kg 
b.w., p.o. respectively. 30 min after aspirin and KVNC administration, group II and III 
received acetic acid (1% v/v, 10 ml/kg b.w., i.p.) and writhing reflex was noted for the 
period of 15 min. 
4.4.2. Evaluation of Acute Anti-inflammatory activity 
Carrageenan induced rat paw oedema 
         The rats were divided into four groups containing six rats in each group. 0.1s ml 
of 1.0% carrageenan in normal saline (0.9% w/v NaCl) was injected to the sub plantar 
region of right hind paw. The trial drug KVNC was administered to the rats 1 h before 
carrageenan injection. Different groups were treated as follows: 
Group I: Carrageenan (0.1 ml of 1.0% carrageenan/rat to the sub plantar region).  
     Group II: Carrageenan + Indomethacin (10 mg/kg b. w., p. o.) 
     Group II and IV: Carrageenan + KVNC (100 mg/kg and 200 mg/kg b. w., p. 
o.respectively).  
          The paw volume was measured initially and at 1, 2, 3 and 4 h after carrageenan 
injection, using Plethysmograph, inflammation was calculated for comparison
[75,76]
.  
Evaluation of Chronic Anti-inflammatory activity 
Cotton pellet granuloma pouch method 
Chronic inflammation was induced by cotton pellet granuloma method. Rats 
were divided into four groups. First two groups received oral doses of 100 mg/kg and 
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200 mg/kg of KVNC respectively. The reference drug indomethacin (10mg/kg) was 
used as a positive control and the other negative control group received saline solution. 
Sterilized Cotton pellets 50 mg were implanted under light ether anesthesia in the axilla 
and groin region of each rat by making a small incision Drugs (KVNC 100, KVNC 200 
and Indomethacin) and saline (5ml/kg) for control group were administered orally to 
four groups of rats once daily for 7 consecutive days from the day of cotton pellet 
implantation. The 8th day, the animals were sacrificed and cotton pellets were removed 
and dried in an oven at 600C for 24 hours.  
They were then weighed. The granuloma formation was calculated as a measure 
of increment in the dry weight of the pellet. The percentage of inhibition of granuloma 
was calculated using the following formula. P = (1 - Wt /Wc) × 100, where, Wt – Dry 
weight of the cotton in test animals and Wc - Dry weight of the cotton in control 
animals. 
4.4.3. Evaluation of Anti-Rheumatic activity 
Collagen induced arthritis in rats 
Collagen induced arthritis is an experimental auto immune disease that can be 
elicited in susceptible strains of rodent and non-human primates by immunization 
with type II collagen, the major constituent protein of articular cartilage. 
Collagen-induced arthritis (CIA) shares both immunological and pathological 
features with human rheumatoid arthritis (RA) therefore it has been used extensively as 
a model to study the pathogenesis of RA and for testing therapeutics.  
The development of arthritis is associated with high levels of both cell mediated 
and humoral immunity to type II collagen. The arthritic response appears to be due to 
collagen immunity. In addition, the histopathology of collagen induced arthritis 
resembles that seen in human rheumatoid arthritis in that lesion is one  of  synovial  
proliferation that  progresses to  pannus  formation  and  results  in marginal erosions 
with extensive destruction of cartilage. 
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5. RESULTS AND DISCUSSION  
There are many studies have been carried out to bring the potency, efficacy and 
safety of the drug Keelvayu Nivarana Chooranam.  
This study includes: 
 Literary collections 
 Organoleptic character 
 Physicochemical analysis 
 Phytochemical analysis 
 Instrumental analysis 
 Toxicological study  
 Pharmacological study  
The drug  Keelvayu Nivarana Chooranam has been selected for Anti-Rheumatic 
activity. 
Standardization of the test drug KVNC 
 Standardization of the drug is more essential to derive the efficacy, potency of 
the drug by analyzing it by various studies. Following are the results of 
physicochemical and phytochemical analysis. Physical characterization and estimation 
of basic and acidic radicals have been done and tabulated.  
Organoleptic Character 
 The following characters have been noted in Keelvayu Nivarana Chooranam.
                      Table No.5.  Results of Organoleptic characters 
Colour Brown 
Odour Pleasant 
Taste Bitter 
Texture Fine powder 
Particle size Completely pass 
through sieve no 88 
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PHYSICOCHEMICAL ANALYSIS  
    Table No.6. Results of Physicochemical analysis 
S.NO PARAMETER RESULT 
1 pH 5.58 
2 Total ash 4.78 
3 Water soluble ash 2.75 
4 Acid soluble ash 0.40 
5 Loss on drying (at 105°C) 5.20 
5 Water soluble extractive 16.65 
6 Alcohol soluble extractive 16.10 
 7 Solubility +ve 
  i Distilled water Soluble 
 ii Benzene Soluble 
iii  Chlroform Soluble 
8 Action on heat - ve 
9 Flame test - ve 
10 Ash test - ve 
 
Interpretation  
 The physical characterization of the drug result reveals the solubility, pH, action 
on heat, flame test and ash test.  
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 pH:  It is a measure of hydrogen ion concentration; it is the measure of 
the acidic or alkaline nature. 7.0 is neutral, above 7.0 is alkaline and below is 
acidic. 
 The pH of the drug is 5.58 which are slightly acidic in nature and it is essential 
for its bioavailability and effectiveness.  
 The result concludes that the oral bioavailability of the drug Keelvayu Nivarana 
Chooranam is very high. 
 Ash is the inorganic residue left after ignition at 650-700°C. The ash content is 
an approximate measure of the mineral content and other inorganic matter in 
biomass.  
 The ash content is a measure of the total amount of minerals present within a 
food, whereas the mineral content is a measure of the amount of specific 
inorganic components present within a food, such as Ca, Na, K and Cl.  
 The quality of drugs depends on the concentration and type of minerals they 
contain, including their taste, appearance, texture and stability.  
 Ash is one of the components in the proximate analysis of biological materials, 
consisting mainly of salty, inorganic constituents.  
 It includes metallic salts which are important for processes requiring ions such 
as Na
+
 (Sodium), K
+
 (Potassium), and Ca
2+
 (Calcium).  
 The ash value of Keelvayu Nivarana Chooranam indicates the presence of 
minerals such as Sodium, Potassium and Calcium.  
 The acid insoluble value of the drug Keelvayu Nivarana Chooranam is 0.40% 
 Solubility is the basic requirement for the absorption of the drug from GIT. 
Here the water soluble nature of Keelvayu Nivarana Chooranam is 16.65 %.  
 This nature might be helpful for the better absorption.  
 To determine the moisture content of a sample, although occasionally it may 
refer to the loss of any volatile matter from the sample.   
 Here the loss of drying value of the trial drug Keelvayu Nivarana Chooranam is 
5.20% at 105°C (%). 
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PHYTOCHEMICAL ANALYSIS  
Table No: 7 Results of Phytochemicals screening  
PHYTOCHEMICALS TEST RESULT 
 
1. Alkaloids 
a. Mayer’s test ++ 
b. Wagner’s test - 
c. Dragendroff’s test - 
d. Hager’s test - 
2. Carbohydrates a. Molisch’s test + 
 
3. Reducing sugars 
a. Benedicts test - 
b. Fehling’s test - 
4.Anthranol Glycosides Modified Borntrager’s test + 
5. Saponins a. Froth test + 
b. Foam test - 
6. Tannins Gelatin test ++ 
7. Phenols Alcoholic Ferric chloride 
test 
+ 
8. Phytosterols Ferric chloride acetic acid 
test 
- 
9. Diterpenes Copper acetate test - 
10. Triterpenes Salkowski’s test - 
11. Flavanoids Alkaline reagent test +++ 
b. Lead acetate test - 
c. Ferric chloride test - 
d. Shinoda test + 
12. Proteins a. Xanthoproteic test - 
 b. Biuret’s test + 
 c. Million’s test - 
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Interpretation 
Phytochemicals are natural bioactive compound found in plants and fibers which 
act as a defense system against diseases and more accurately, to protect against diseases. 
The phytochemical analysis reveals the presence of alkaloids, tannins, flavonoids, 
anthral glycosides, cardiac glycosides, saponins, phenols, proteins and carbohydrates.  
Flavonoids 
 It is the most important group of polyphenolic compounds in plants. 
 Flavonoids have potent Anti-Oxidant activity and it is its important function. 
 It also possesses anti-microbial activity which is confirmed by the various anti-
microbial assays.  
Tannins 
 Reported to have anti-arthritic activity.  
 They restore the Anti-Oxidant status of the organs to almost normal levels. 
 Increases the cellular Anti-Oxidant enzymes. 
 Helps in healing of wounds and inflammation of mucous membrane. 
Phenols 
 They possess rich Anti-Oxidant property and protect body from oxidative stress. 
 Phenol groups are the essential part of many anti-oxidant compounds 
Alkaloids 
 Alkaloids possess antispasmodic, analgesic, anti-inflammatory, bactericidal 
effects. 
 Alkaloids are the active principles producing many essential effects in protecting 
the body. 
A synergistic effect of all these flavonoids, alkaloids, glycosides, tannins, 
phenols, saponins, increases the potency of the drug against Rheumatoid Arthritis. 
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HPTLC (HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY)  
Stationary Phase - Silica Gel 60 F254 
Mobile Phase - Hexane: Ethyl Acetate:  (7.5:2.5 v/v) 
 
 
 
 
 
 
           λ  = 254 nm                 λ= 366 nm  
 
λ=520nm     
(Derivatized) 
                      Fig. No.8. Results of HPTLC 
  Table No.8.  Rf value for chloform extract  
Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
Dark 0.07 Red 0.05 Ash  0.08 
Dark 0.10 Red 0.14 Violet 0.11 
Dark 0.14 Red 0.20 Ash  0.24 
Dark 0.25 Red 0.27 Violet 0.31 
Dark 0.44 Red 0.30 Violet 0.45 
Dark 0.54 Red 0.37 Light Blue 0.55 
Dark 0.58 Bluish Red 0.39 Ash  0.69 
Dark 0.50 Red 0.62 Ash 0.74 
Dark 0.54 Yellow 0.73 Dark grey 0.82 
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 Under UV 254 nm, it shows major spots at Rf   0.07, 0.10, 0.14, 0.25, 
0.44, 0.54, 0.58, 0.50, 0.54 major compounds are found. 
 Under UV 366 nm, it shows major spots at Rf   0.05, 0.14, 0.20, 0.27, 
0.30, 0.37, 0.62,0.73,  
 
 
 
 
 
   
  Graph No.1. TLC Chromatogram at 254 nm 
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  Graph No.2. 3D Chromatogram at 254 nm 
 
 
             Table No.9. Peak value at 254 nm 
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Interpretation 
 The quantitative analysis of compounds present in the KVNC has been 
performed by HPTLC.  
 The method may be applied to identify the KVNC from other manufacturing 
process.  
 It provides the identification of constituents, determination of impurities and 
quantitative determination of active substance present in KVNC.
 [77 ]
 
 The Rf value of the KVNC supports the better standardization of the drug. 
 The present study revealed that KVNC showed best results in Toluene: Ethyl 
Acetate (9:1) Solvent system.  
 After scanning and visualizing the plates in absorbance mode at 254nm, 366nm 
and 520nm. Best results were shown at visible light range. 
 TLC plate showed different colour phyto constituents of chloroform extract of 
KVNC.  
 The bands revealed presence of six green, two blue and one fluorescent yellow, 
bands showing the presence of alkaloids, glycosides, phenols, triterpenes, 
flavonoids and quinines. 
 The results from HPTLC finger print scanned for chloroform extract of KVNC.  
 There are thirteen polyvalent phytoconstituents and corresponding ascending 
order of Rf values start from 0.02 to 0.92 in which highest concentration of the 
phyto constituents was found to be 28.96% and 27.95% with its corresponding 
Rf value found to be 0.02 and 0.92 respectively.    
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BIOCHEMICAL ANALYSIS  
Table No: 10 Results of Basic radicals studies 
   
 
Interpretation
 [78] 
 The basic radical test shows the presence of Potassium, Calcium, 
Magnesium, Sodium and Iron.  
 Potassium is extending to improving the health of bones. There are 
certain qualities of potassium which neutralize various acids throughout 
the body which retain and preserve calcium, making it inaccessible to use 
for bone strength and durability.  
 Calcium strengthens the backbone and ensures the right shape to the 
body, as well as helping to alleviate the presence of joint pain. It helps to 
keep the bones in their proper shape and prevents many skeletal 
complaints like arthritis and osteoporosis, which could hamper your 
freedom of movement, as well as being extremely painful. 
 Sodium helps to facilitate the absorption of glucose by cells, resulting in 
the smooth transportation of nutrients in the body’s cell membranes. 
S.NO PARAMETER 
 
OBSERVATION RESULT 
1 Test for Potassium Yellow colour precipitate + ve 
 
2 Test for Calcium 
 
White colour precipitate 
 
+ve 
3 Test For Magnesium 
. 
White colour precipitate 
 
+ve 
4 Test For Sodium 
 
Intense yellow colour 
 
+ ve 
5 Test for Iron (Ferrous) Blood red colour +ve 
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 Iron is a vital element for muscle health. It is present in the muscle 
tissues and helps to provide the supply of oxygen required for contraction 
of muscles. Without it, muscles lose their tone and elasticity. 
    
   Table No.11. Test for Acid radical studies 
S.NO PARAMETER OBSERVATION RESULT 
1 Test for Sulphate Formation of white 
precipitate 
+ ve 
2 Test for Phosphate Formation of 
Yellow precipitate 
+ ve 
 
 
Interpretation 
 The acidic radicals test shows the presence of Sulphate and Phosphate. 
 Sulphates are important in forming proteins in the joints.  
 Phosphate works in association with calcium to create strong bones, 
which can withstand the normal wear and tear of human life. It also helps 
in relieving serious problems like bone loss or the loss of mineral 
density, also known as osteoporosis. This mineral lays the foundation of 
a strong skeletal structure to ensure health and functional living. 
 
MICROBIAL LOAD 
Table No.12. Bacterial and fungal dilutions 
         MICROBES      DILUTION         RESULT 
         Bacteria            10
-4 
              15 
         Bacteria            10
-6 
              11 
         Fungi            10
-2 
                8 
         Fungi            10
-3 
                4 
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Interpretation 
 The availability of bacterial load in the KVNC has been performed by Agar 
plate technique. 
 As KVNC is made from plant material it is more prone to contamination. The 
contamination of herbal drugs by microorganism not only cause bio 
deterioration but also reduces the efficacy of drugs. 
 The toxin produced by microbes makes herbal drugs unfit for human 
consumption because the contaminated drug may develop unwanted disease 
instead of disease being cured. 
 The contamination of KVNC has been examined by bacterial and fungal load. 
 Total bacterial load in 10-4 dilution is 15 and 10-6 dilution 11. 
 Total fungal load in 10-2 dilution is 8 and 10-3 dilution is 4. 
This result shows the presence of bacterial and fungal load in the trial drug 
(KVNC). The load of bacteria and fungi are within the limits of WHO norms. 
FTIR (FOURIER TRANSFORM INFRARED SPECTROSCOPY) 
 
 
Graph No.3. FTIR Spectrum       
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 450.0 
0.0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
70 
75 
80 
85 
90 
95 
100.0 
cm-1 
%T  
 
3370 2972 
2933 
2886 
2659 
2195 
1649 
1466 
1407 
1380 
1341 
1306 
1161 
1129 
952 
817 
678 
RESULTS & DISCUSSION  
 
 
 
              ANTI-RHEUMATIC ACTIVITY OF KEELVAYU NIVARANA CHOORANAM 
112 
Table No.13. Interpretation of FTIR Spectrum 
 
ABSORPTION 
PEAK CM
-1 
 
STRETCH 
 
 
FUNCTIONAL 
GROUP 
         3370 N-H stretch 1,2 Amines, Amide 
 
         2972 C-H Stretch Alkanes  
 
         2933 C-H Stretch Alkanes  
 
         2886 C-H Stretch Alkanes  
 
         2195 -C=C Stretch Alkenes  
 
         1649 -C=C Stretch Alkenes  
 
         1466 C-H bend  Alkanes  
 
         1161 C-H way (-CH2X) Alkyl halides 
       1129 C-H way (-CH2X) Alkyl halides 
         952 =C-H bend Alkenes 
         817 C-Cl Stretch Alkyl halides 
        678 C-Br Stretch Alkyl halides 
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Interpretation 
FTIR instrumental analysis was done. The test drug was identified to have 15 peaks. 
They are the functional groups present in the trial drug Keelvayu Nivarana Chooranam. 
The above table shows the presence of amide, phenols, alkanes, alkyl halides 
alkynes, alkenes, ester, aromatics and alcohol groups which represents the peak value. 
 OH group has higher potential towards inhibitory activity against 
microorganisms.  
 Phenols possess highly Anti-Oxidant property which enhances the drug effect 
against the disease. 
ICP-OES (INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION 
SPECTROSCOPY) 
                                    Table No.14.  ICPOES Interpretation 
S. NO ELEMENTS DETECTED LEVELS 
1 Al 396.152 BDL 
 
2 As 188.979 BDL 
 
3 Ca 315.807 
 
221.160 mg/L 
4 Cd 228.802 BDL 
 
5 Cu 327.393 BDL 
 
6 Hg 253.652 
 
BDL 
7 K 766.491 
 
43.114 mg/L 
8 Mg 285.213 01.324 mg/L 
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S. NO ELEMENTS DETECTED LEVELS 
9 Na 589.592 
 
05.310 mg/L 
10 Ni 231.604 
 
BDL 
11 Pb 220.353 
 
BDL 
12 P 213.617 
 
104.341 mg/L 
13 Zn 206.200 
 
01.208 mg/L 
 
 From the above results, the heavy metals Aluminium, Cadmium, Hg, and 
Lead were found below detection level.  
 Calcium, potassium, Magnesium, Sodium is found to have remarkable 
benefit in anti-arthritic therapy. 
 Calcium is crucial in growing new bone and maintaining bone strength. 
Calcium supplements are standard for treating and preventing 
osteoporosis. 
 Magnesium’s benefits can include reduced symptoms from conditions 
such as chronic pain, fatigue and insomnia. Magnesium may also provide 
protection from a number of chronic diseases, especially those associated 
with arthritis. 
[79]
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XRD (X-Ray diffraction)             
 
                  Graph No: 4 XRD - Interpretation 
Interpretation 
 The structure, the size and shape of the particles are highly dependent on the 
route of synthesis and high lights the efficacy of the drug. The micro particles may 
enhance bio absorption of the drug. 
 The major diffraction peaks are identified after XRD analysis KVNC concluded 
that range 48-75nm is association with organic molecules probably plays an important 
role in making it biocompatible and nontoxic at therapeutic doses.  
 Other elements present in KVNC act as additional supplement and possibly 
helps in increase the efficacy of the formulation. 
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SEM (Scanning Electron Microscope) 
 
In addition, the particle size and chemical elements were assessed by Scanning 
Electron Microscope SEM is one of the most widely used instruments in research areas.  
 
        
 
                    
                   Fig. No.9.  Showing of micro particles of KVNC 
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The above SEM studies of microscopic resolution of 1.00kx and examining 
surface area of 800x800µm
2
. The surface of the sample grains is uniformly arranged in 
agglomerates. They are micro particles ranging from 500nm - 1μm. 
Size and surface of micro particles can be easily manipulated to achieve both 
active and passive drug targeting. They 
 control release of the drug 
 sustain release of the drug during the transportation 
 alters distribution of the drug 
 subsequently clear the drug 
 increase drug therapeutic efficacy 
 increase bio-availability 
  reduces side effects 
 
TOXICITY STUDY RESULTS OF KVNC 
 
Acute oral toxicity study of Keelvayu Nivarana Chooranam 
 
  Wistar albino rat was treated with the test drug Keelvayu Nivarana Chooranam 
of single dose of 200mg/kg. This study was conducted as per the OECD guidelines.  
The result of acute toxicity of Keelvayu Nivarana Chooranam has been 
tabulated below. 
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Table No.15. Dose finding experiment and its behavioral Signs of acute oral 
Toxicity (Observation) 
S.No              Group 
          CONTROL 
Observation S.No Group 
TEST GROUP 
Observation 
1 Body weight Normal 1 Body weight Normally 
increased 
 2 Assessments of posture Normal 2 Assessments of 
posture 
Normal 
3 Signs of Convulsion 
Limb paralysis 
Normal 3 Signs of Convulsion, 
Limb paralysis 
 
 
 
Absence of sign 
(-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color No significant 
color change 
7 Change in skin color No significant 
color change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 10 Sensitivity response Normal 10 Sensitivity response Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
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Table No.16. Dose finding experiment and its behavioural Signs of Toxicity for 
KVNC 
No Dose mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - - - 
2. 2000 
mg/kg 
 
+ - - + - + - - - - - - - - - - - - - - 
 
1..Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhea 18. Writhing 19. Respiration 20. Mortality. 
(+  Present, -  Absent) 
Interpretation 
 The Acute toxicity result shows no mortality rate up to 2000mg/kg. It showed 
changes in alertness, grooming and touch response. The behavioural changes are 
normal. This dose level did not produce signs of toxicity, behavioral changes, and 
mortality in the test groups as compared to the controls when observed during 14 days 
of the acute toxicity experimental period. Hence the test drug Keelvayu Nivarana 
Chooranam is a safe herbal drug and can be used for long time administration.  
Table No.17. Body weight Observation 
 
 
 
 
 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
1 7 14 
Control 176.21± 3.22 177.2± 4.27 179.2 ± 4.82 
200 mg/kg 172.5± 3.18 174.2± 3.26 175.4 ± 3.27 
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Table No: 18 Water intakes (ml/day) of Wistar albino rats group exposed to 
KVNC 
 
 
 
 
 
 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
Table No.19.  Food intakes (gm/day) of Wistar albino rats group exposed to KVNC 
 
DOSE 
 
DAYS 
1 7 14 
Control 32.56±2.16 32.92±3.26 30.92±3.26 
200 mg/kg 34.12±8.64 34.31±1.22 35.22±2.24 
P value (p)* NS NS NS 
 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
Interpretation 
 The result of the body weight of rats exposed to control and the trial drug 
of Keelvayu Nivarana Chooranam 200 mg exhibited overall mild weight 
gain throughout the dosing period of 14 days.  
 The quantity of water and food intake taken by the animals from the 
group and the control is comparably normal. 
 
 
DOSE 
 
                                    DAYS 
           1            6          14 
Control 38.7 ± 2.74 32.9± 4.33 33.4± 4.13 
200 mg/kg 32.4±1.34 33.5±1.11 35. 9± 4.19 
P value (p)* NS NS NS 
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    REPEATED DOSE 28- DAY ORAL TOXIC STUDY OF KVNC 
 
Table No: 20 Body weight of wistar albino rats group exposed to KVNC 
 
NS- Not Significant, ** (p > 0.01),*(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
Table No: 21 Water intakes (ml/day) of Wistar albino rats group exposed to 
KVNC 
DOSE 
 
                                                     DAYS 
1 6 14 21 28 
Control 31.5 ± 8.95 32.0 ±6.23 28.5±6.23 29.12±8.19 31.5±3.96 
 
Low Dose 29.5±3.31 29.9±6.62 31.7±4.02 32.2±4.29 34.9±3.13 
 
Mid Dose 31.7±3.93 32.3±3.11 34.1±2.83 32.4±4.11 34.4±2.14 
 
High Dose 32.1±1.12 33.2±2.43 34.7±2.53 35.2±1.89 36.4±2.45 
 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
 
DOSE 
 
                                               DAYS 
1 7 14 21 28 
CONTROL 165.6±  2.76 166.4 ± 3.42 167.7 ± 3.26 169.2 ± 3.73 170.7 ± 1.31 
LOW DOSE 165.2 ± 4.12 166.7 ± 2.64 166.9± 1.51 172.9 ± 1.66 174.42± 2.76 
MID DOSE 168.6± 1.24 168.9 ± 4.74 170.4 ± 8.92 171.1 ± 6.36 174.7 ± 9.12 
HIGH DOSE 171.4± 3.74 173.6 ± 6.32 174.6 ± 2.86 175.1± 8.82 175.92 ± 6.42 
P value (p)* NS NS NS NS NS 
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Table No.22. Food intake (gm/day) of Wistar albino rats group exposed to KVNC 
DOSE 
 
                                            DAYS 
1 7 14 21 28 
Control 37.12 ±5.37 38.5±3.22 39.5±3.37 38.5±3.37 37.12±3.12 
Low Dose 33.7±2.12 35.3±1.42 35.9±1.68 36.4±2.62 35.9±8.42 
Mid Dose 34.2±3.64 35.9±3.64 36.2±6.15 37.4±2.18 35.2±2.64 
High Dose 36.2±2.14 36.2±2.18 37.6±2.14 38.2±4.28 39.2±2.18 
P value (p)* NS NS NS NS NS 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
Table No.23. Haematological parameters of Wistar albino rats group exposed to 
KVNC 
CATEGORY CONTROL LOW DOSE MID DOSE HIGH DOSE 
Hb(g/dl) 14.8±1.88 12.98±1.28 13.01±1.26 14.18±3.96 
Total WBC ×10
3 
 10.91±2.59 12.25±3.53 12.18±3.61 12.96±3.47 
Neutrophils (%) 32.65±1.06 34.23±2.54 34.91±1.36 33.40±2.80 
Lymphocyte (%) 69.34±2.48 70.22±3.42 71.48±2.66 71.20±3.96 
Monocyte (%) 0.78±0.17 0.81±0.12 0.84±0.11 0.95±0.16 
Eosinophil (%) 0.64±0.09 0.19±0.12 0.78±0.06 0.42±0.04 
Platelets cells10
3
/µl 687.17±8.76 698.71±8.16 705.18±4.0 712.16±4.6 
Total RBC 10
6
/µl 7.99±0.12 6.82±1.87 6.92±0.59 6.18±0.72 
PCV% 37.79±0.6 36.35±1.53 38.2±1.18 36.82±2.14 
MCHC g/dl 33.6±2.23 34.19±1.19 35.18±1.92 34.13±1.94 
MCV (µm
3
) 49.17±3.64 48.20±1.24 49.28±1.24 49.99±1.84 
N.S- Not Significant, ** (p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table No: 24 Biochemical parameters of Wistar albino rats group exposed to 
KVNC 
BIOCHEMICAL 
PARAMETERS 
CONTROL LOW DOSE MID DOSE HIGH 
DOSE 
Glucose (r) (mg/dl) 76.45±13.4 76.16±8.54 79.64±9.20 77.42±11.6 
T.Cholesterol  
(mg/dl) 
115.26±1.83 112.45±1.13 112.42±1.98 115.22±1.83 
Tri Glycerides 
(mg/dl) 
46.35±1.48 45.32±1.48 45.58±1.26 46.66±1.45 
LDL 72.81±2.13 70.14±2.34 71.8±2.94 72.64±6.12 
VLDL 15.2±2.44 14.42±4.63 14.44±6.64 14.94±5.14 
HDL 26.66±6.88 27.96±2.34 27.88±5. 66 29.78±6.22 
Ratio 
1(T.CHO/HDL) 
4.42±2.44 4.36±1.44 4.84±2.44 4.86±1.92 
Ratio 2(LDL/HDL) 2.83±4.22 3.02±1.52 2.96±4.80 2.86±3.82 
Albumin(g/dL) 3.63±0.17 3.13±1.12 3.10±1.92 2.94±3.86 
  
NS- Not Significant** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D   
(One way ANOVA followed by Dunnett’s test) 
 
Table No 25: Renal function test of of Wistar albino rats group exposed to KVNC 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
Urea (mg/dl) 13.35±0.99 12.91±1.86 13.16±1.98 13.18±3.92 
Creatinine(mg/dl) 0.28±0.08 0.16±1.16 0.12±0.14 0.18±1.22 
Bun(mg/dl) 15.02±0.10 14.80±1.20 14.66±0.44 15.10±2.32 
Uric Acid(mg/dl) 5.17±0.35 5.25±1.43 5.02±1.35 5.18±1.08 
 
 NS- Not Significant, ** (p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table No 26: Liver Function Test of of Wistar albino rats group exposed to KVNC 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH 
DOSE 
T.BILIRUBIN(mg/dl) 0.48±0.07 0.43±1.26 0.64±1.28 0.68±1.25 
AS(U/L) 79.95±1.39 77.15±1.31 78.71±1.83 80.35±3.03 
ALT(U/L) 31.23±1.28 31.81±3.52 30.14±3.18 31.9±1.88 
ALP(U/L) 143.25±8.70 141.9±8.17 142.16±4.10 144.33±4.2
5 
T.PROTEIN(g/dL) 5.32±0.38 5.28±0.34 5.21±1.33 5.13±1.06 
 
NS- Not Significant, ** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
From the maximum tolerable dose 200mg/kg 1/5, 1/10 and 1/20th dose were 
selected for further sub-acute toxic study. In sub-acute toxicity study 28 days duration 
was followed. The signs and symptoms of toxicity were noted. The animals treated with 
Keelvayu Nivarana Chooranam 200mg/kg showed no statistically significant body 
weight changes during four weeks of drug treatment. There was no major change in the 
haematological parameters. After the experimental period the biochemical results 
indicates that there were no significant changes in Total protein, Hb, Globulin, GGT, 
Chloride, HDL, VLDL, total bilurubin, and Triglycerides. From the urine routine 
analysis the drug treatment indicates no significant changes in the pH of urine, bilurubin 
and Ketones.  
Body weight 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight gain throughout the dosing period 
of 28 days.  
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The quantity of food taken by the animals from different dose groups and the 
control is comparably normal. 
Haematological investigation interpretation 
 The haematological investigation results of the rats conducted on 28
th
 day after 
the repeated dose of the drug revealed the values of different parameters.  
The increase and decrease in the values obtained were all within the normal 
biological and laboratory limits. 
Biochemical investigation interpretation 
The biochemical investigations were conducted on 28
th
 day and the result is 
produced.  
The results revealed there is no significant change in the values of different 
parameters with that of the control. All the values were within the normal biological and 
laboratory limits.  
Renal Function Test analysis 
 Renal Function Test analysis data of control group and the test groups of 
animals taken on 28
th
 day showed no abnormal results. 
Liver Function Test analysis 
Liver Function Test analysis data of control group and the test groups of animals 
taken on 28
th
 day showed no abnormal results. 
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Interpretation 
 The above slides show the histopathology studies of sub-acute toxicity. There is 
no toxicological abnormality seen in the vital organs after administration of the test drug 
Keelvayu Nivarana Chooranam.  
Mortality in the repeated oral toxicity test was not seen in the limit test up to 
high dose. Maximum tolerable dose was considered for the further pharmacological 
studies. No other toxic symptoms were observed in any of the dose treated animals. 
Thus the safety of the drug is revealed so that it can be administered for long 
time without any side effects. 
         ANALGESIC ACTIVITY OF KVNC 
Acetic acid induced writhing in rat 
Table No: 27 Analgesic effect of KVNC on acetic acid induced writhing in rat 
 
Groups Treatment Dose Mean of writhing 
± SEM (sec) 
% of 
Inhibition 
Group I 
(control) 
Acetic acid (1% 
v/v) 
10 mg/kg 33.53±0.87 _ 
GroupII 
(standard) 
Acetic acid + 
Aspirin 
100 mg/kg 5.68±0.53*** 84.85% 
Group III  
 
Acetic acid + 
KVNC 
100 mg/kg 8.25±0.60*** 75.76% 
Group IV 
 
Acetic acid + 
KVNC 
200 mg/kg 7.85±0.42*** 78.79% 
 
  Values are mean ± SEM (n = 6 Dunnett’ test). ***p< 0.001 when compared to 
control. 
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                     Graph No.5. Analgesic activity of KVNC 
 
 
   
 
                       Graph No.6. Percentage inhibition of KVNC 
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Writhing method is the most common test for evaluating the analgesic efficacy 
of drugs/compound in rodents. Abdominal constrictions in rats were caused by the 
intraperitoneal injection of acetic acid.  
 The animals were previously treated, by oral administration (p.o.) with Keelvayu 
Nivarana Chooranam 1 h before the stimulation with acetic acid. Control animals 
received the same volume of vehicle. Five minutes after the acetic acid injection, the 
number of times that each animal presented abdominal constriction was counted for 20 
consecutive minutes. The abdominal constriction response induced by glacial acetic 
acid is a sensitive procedure to establish peripherally acting analgesics. This response is 
thought to involve local peritoneal receptors.  
 The number of writhing observed during a 20 min period in control group was 
33.53±0.87. It was also observed that animals in test group showed delayed onset of 
writhes (after 10min) as compared to other groups in which onset of writhes was within 
5 min. The Keelvayu Nivarana Chooranam (100 mg/kg, p.o.) showed the significant 
(P<0.001) reduction in the number of writhes induced by acetic acid. Aspirin 
significantly reduced the number of writhes (P<0.001). There was a significant, 
inhibition of pain response in rats.   
The Acetic acid -induced writhing response is believed to be produced by the 
liberation of endogenous substance, notably metabolites of the arachidonic cascade. 
Hence, Acetic acid causes analgesia by liberating endogenous substances including 
serotonin, histamine, bradykinin which stimulates pain nerve endings. Local peritoneal 
receptors are postulated to be partly involved in the abdominal constriction response.  
 The method has been associated with prostanoids in general, i.e. increased levels 
of PGE2 and PGF2α in peritoneal fluids as well as lipoxygenase products. Therefore, the 
Keelvayu Nivarana Chooranam might inhibit the synthesis and/or release of these 
endogenous substances. Significant reduction in abdominal constriction compared with 
vehicle treated animals was considered as antinociceptive response. So it can be 
concluded that the Siddha drug Keelvayu Nivarana Chooranam possess excellent 
peripheral analgesic property which is equipotent to standard drug used in this study. 
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ACUTE ANTI-INFLAMMATORY ACTIVITY OF KVNC 
Carrageenan induced rat paw oedema 
Table No: 28 Results of the acute anti-inflammatory activity of KVNC 
Values are mean ± SEM (n = 6) (Dunnett' test). *** p < 0.001 when compared 
to control 
                           
                       Graph No.7.  Acute Anti-inflammatory activity of KVNC 
 
Groups Treatment 1h 2h 3h 4h % of 
Inhibition 
Group I 
(Control) 
Carrageenan 
(1% w/v) 
0.74±0.01 1.39±0.04   1.70±0.02 1.66±0.01 _ 
Group II 
(Standard) 
Carrageenan + 
Indomethacin 
(10 mg/kg) 
0.23±0.01 
   
0.52±0.01   0.35±0.01 0.24±0.01*** 85.55% 
Group III 
 
Carrageenan + 
KVNC  
(100 mg/kg) 
0.33±0.01 
  
0.52±0.01 0.50±0.01 0.33±0.01*** 80.13% 
Group IV  Carrageenan + 
KVNC 
(200 mg/kg) 
0.34±0.01 
 
0.52±0.01 0.45±0.01 0.36±0.01*** 81.33% 
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The carrageenan-induced hind paw oedema model in rats is known to be the 
acute inflammatory model sensitive to cyclooxygenase (COX) inhibitors and has been 
used to evaluate the effect of nonsteroidal anti-inflammatory agents (NSAID), which 
primarily inhibit the cyclooxygenase involved in prostaglandin (PG) synthesis. In case 
of the time course of oedema development in carrageenan induced paw edema model in 
rats is generally two phases are found.  
The first phase, which occurs between 0 to 2.5 h of injection of the phlogistic 
agent, has been attributed to the release of histamine or serotonin. The edema volume 
reaches to its maximum approximately 3 h post treatment and then begin to decline. The 
second phase of inflammatory reaction which is measured at 3h is caused by the release 
of bradykinin, protease, prostaglandin and lysosome.  
Therefore, it can be inferred that the inhibitory effect of the extract on the 
carrageenan induced inflammation could be due to the inhibition of enzyme 
cyclooxygenase leading to inhibition of prostaglandin synthesis. Thus, the results of the 
present study demonstrate that the Keelvayu Nivarana Chooranam exhibited acute anti-
inflammatory activity in the tested models which was found to be the most effective at 
higher concentrations employed.  
  
CHRONIC ANTI- INFLAMMATORY ACTIVITY OF KVNC 
Cotton pellet granuloma pouch method 
Table No: 29 Results of the Chronic Anti-inflammatory activity of KVNC 
S.No Treatment Dose (mg/kg) Granuloma 
weight (mg)% 
% of 
Inhibition 
1. Control 5ml/kg 
 
42.66±0.88 -- 
2.  Indomethacin 10mg/kg 
 
18.83±0.94*** 57.15% 
3. KVNC 100mg/kg 
 
24.66±1.14*** 42.86% 
4. KVNC 200mg/kg 
 
23.16±1.01*** 45.24% 
       
      Values expressed in mean ±SEM (Dunnett’ test), ***P<0.001 compared to control. 
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 Graph No.8. Chronic Anti-inflammatory activity of KVNC 
 
Cotton pellet granuloma pouch method 
Chronic inflammation was induced by cotton pellet granuloma method. Rats 
were divided into four groups. First two groups received oral doses of 100 and 200 
mg/kg of KVNC respectively. The reference drug indomethacin (10mg/kg) was used as 
a positive control and the other negative control group received saline solution. 
Sterilized Cotton pellets 50 mg were implanted under light ether anesthesia in the axilla 
and groin region of each rat by making a small incision Drugs (KVNC 100mg, KVNC 
200mg and Indomethacin) and saline (5ml/kg) for control group were administered 
orally to four groups of rats once daily for 7 consecutive days from the day of cotton 
pellet implantation.  
The 8th day, the animals were sacrificed and cotton pellets were removed and 
dried in an oven at 600C for 24 hours. They were then weighed. The granuloma 
formation was calculated as a measure of increment in the dry weight of the pellet. The 
percentage of inhibition of granuloma was calculated using the following formula.  
P = (1 - Wt /Wc) × 100, where, Wt – Dry weight of the cotton in test animals 
and Wc - Dry weight of the cotton in control animals.  Statistical Data were presented as 
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mean ± S.E.M. Statistical differences between control and treated groups were tested by 
one way ANOVA followed by dunnett’s test. 
The percentage of inhibition of granuloma in Cotton pellet granuloma pouch 
method is shown in table. From this result it was observed that both doses of Keelvayu 
Nivarana Chooranam (KVNC 100 mg and KVNC 200 mg) significantly inhibited 
granuloma weight (P<0.05 and P < 0.01 respectively) when compared to the control 
group.  
The percentage of inhibition of KVNC 100 mg and KVNC 200 mg were 
42.86%and 45.24% respectively which indicated the dose dependent activity of 
Keelvayu Nivarana Chooranam. KVNC 200mg exhibited percentage of inhibition more 
than KVNC 100 mg and slightly less than the reference drug Indomethacin (10mg/kg) 
which produced 57.15% of inhibition. 
ANTI RHEUMATIC ACTIVITY OF KVNC 
Collagen Induced Arthritis in Rats 
Preparation of emulsion 
 
Chicken sternal collagen type II was dissolved in 0.1M acetic acid at a 
concentration of 2mg/ml, kept overnight at 40 C. This solution is added drop wise to an 
equal volume of chilled Incomplete Freunds Adjuant to produce the inducing agent and 
stored on ice before use. The glass wares used in this process were pre- chilled  
 
 Induction of arthritis 
[ 80] 
 
1.  On day 1 each rat receives a total of 0.5mg collagen in 0.5ml equally divided 
in five sites (base of the tail, and region above each limb). 
2.  Administration of booster injection on day 7. The same concentration of the 
emulsion is used as for the primary immunization. Injected 0.1ml of booster emulsion in 
the base of the tail, but different location from the first injection site. 
 
All injections were given in intra-dermal route.  
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Arthritic index 
Arthritic index of animals in all groups were recorded on day 1, 14, 21, 28, 35 
and 40. Data obtained were tabulated in table.  
Following the injections of collagen emulsion, rats developed arthritis beginning 
from day 8 onwards.  
After the onset of treatment the KVNC treated rats show marked reduction in the 
arthritic score CIA rats. 
    Table No.30. Effect of KVNC on arthritic index in collagen induced arthritic rats 
 
ARTHRITIC INDEX 
Days Group I 
(Control) 
Group II 
(Prednisolone) 
Group III 
(KVNC 100mg/kg) 
Group IV 
(KVNC200mg/kg) 
Day 1 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
Day 14 5.33±0.67 7.00±1.12 8.33±1.20 7.33±0.95 
Day 21 14.67±0.61 10.50±0.61 13.6±0.42 12.83±0.74 
Day 28 11.17±1.62 4.67±0.66*** 8.66±0.66 9.33±0.66 
Day 35 11.17±1.38 2.33±0.55*** 8.00±0.89 6.00±0.51** 
Day 40 11.17±1.42 1.16±0.30*** 3.83±0.47*** 2.50±0.22*** 
 
Values plotted were the mean ± SEM (n=6). Significant reductions in score were 
analyzed by using one-way ANOVA followed by Dunnett’s multiple comparisons test. *-
represent statistical significance. **-p<0.01, ***-p<0.001 when compared with control 
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   Graph No: 9 Effect of KVNC on arthritic index 
 
           Table No: 31 Effect of KVNC effect on CRP in CIA induced arthritic rats 
 
Values are as Mean ± SEM (Dunnett’ test); N = 6; *P<0.05, **P 
<0.01,***P<0.001 vs Normal 
 
 
Group Treatment Dose CRP (μg/ml) 
Normal Saline 1ml/kg 166.05±1.46 
Control (RA) Honey alone 1ml/kg 396.59±1.03 
Standard Indomethacin 10mg/kg 204.84±0.65*** 
Test I KVNC+Honey 100mg/kg 225.89±0.41*** 
Test II KVNC+Honey 200mg/kg 210.84±0.68***
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                            Graph No: 10 Effect of KVNC on CRP 
         Table No: 32 Effect of KVNC on heamatological parameters in arthritic rats 
Group Treatment WBC  
(Cells/cu.m) 
RBC count 
(millions/cu.
mm) 
Hb (gm%) ESR 
(mm/hr) 
Normal Saline 
(1ml/kg) 
7.36±0.21 5.89±0.17 14.02±0.04 2.23±0.07 
Control 
(RA) 
Honey 
(1ml/kg) 
7.44±0.21** 5.23±0.03*** 12.37±0.08*** 4.11±0.06*** 
Test KVNC 
(100mg/kg) 
7.53±0.13* 5.55±0.27*** 13.75±1.20*** 3.12±0.46*** 
Test KVNC 
(200mg/kg) 
7.55±0.06 5.54±0.18
*** 
13.59±0.16**
 
3.19±0.19
*** 
Standard Indomethacin 
10mg/kg 
7.60±0.07
 
 5.53±0.16***
 
14.59±0.15** 3.22±0.19*** 
 
Values are as Mean ± SEM (Dunnett’ test); N = 6; *P<0.05, **P 
<0.01,***P<0.001 vs Normal 
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The results of the present study show that the Keelvayu Nivarana Chooranam 
exhibits anti-arthritic effect in rats with collagen-induced arthritis, either on its acute 
and chronic phase. The model of collagen-induced arthritis in rats has been extensively 
used in the study of inflammatory processes and validated as a model of chronic pain. In 
addition, altered sleep pattern has been observed in these animals. The significant 
difference for acute and chronic treatments, demonstrating that the method used for 
induction of arthritis was effective, reducing the pain threshold in the injected animals, 
thus, revealing the applicability of induced arthritis as an experimental model of chronic 
pain.  
 RA develops as a result of interaction of many factors, which include genetic 
(inherited) factors, environmental (viral or bacterial) factors and hormonal factors. A 
variety of tools are used to diagnose RA and these include; medical history, physical 
examination, laboratory test (rheumatoid factor, white blood cell count and erythrocyte 
sedimentation rate, measurement of Hb calculated) and X-rays. The goals of managing 
arthritis are basically the same no matter what treatment approach is chosen; these are to 
relieve pain, reduce inflammation, slow down or stop joint damage and improve a sense 
of wellbeing and ability to function. Rheumatoid arthritis is a progressive, disabling, 
chronic multisystem disease of unknown cause characterized by pain and stiffness of 
synovial joints. 
On day 1 each rat receives a total of 0.5mg collagen in 0.5ml equally divided in 
five sites (base of the tail, and region above each limb). Administration of booster 
injection on day 7. The same concentration of the emulsion is used as for the primary 
immunization. Injected 0.1ml of booster emulsion in the base of the tail, but different 
location from the first injection site. Deregulation of IL-6 expression causes the 
synthesis and release of many inflammatory mediators, which may result in pain and 
edema.  
Due to its multiple stimulatory effects on cells of the immune system and 
vascular endothelial cells, it is believed that excess IL-6 plays a pathogenic role in the 
development of inflammation, resulting in hyperalgesia and edema. Modulation of 
immune responses to alleviate pain and inflammation has been of interest for many 
years 
[81]
. Due to the central role played by IL-6 in a number of manifestations of 
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inflammatory diseases, therapeutic inhibition of IL-6 represents a novel approach to the 
treatment of chronic inflammation.
[82]
  
Studies have demonstrated that some symptoms of inflammation with a 
significant cytokine component, such as rheumatoid arthritis, can be treated by 
inhibition of IL-6. However, IL-6 has been shown to elicit both pro- and anti-
inflammatory effects. 
The erythrocyte sedimentation rate is elevated in various stress conditions, cell 
necrosis and inflammation.  
The ESR is an indirect method for the measurement of inflammation in the 
body. Due to protein production in inflammation, erythrocytes move closer, stack up in 
a group, become denser and settle faster.  
With the increase in erythrocyte settling rate, erythrocyte sedimentation rate also 
increases. The significant low level of ESR in the KVNC treated arthritis rats indicates 
their anti-inflammatory potential. 
Rats exhibited a gradual increase WBC, ESR compared with control group, 
whereas RBC count and haemoglobin percentage decreased compared with control 
group. Here attempt has been made to evaluate pharmacological potential of Keelvayu 
Nivarana Chooranam after stability study by using parameters likes change in arthritic 
score in collagen induced arthritis.  
The result of Anti-Rheumatic activity of KVNC after stability studies showed 
that Keelvayu Nivarana Chooranam is having better anti-rheumatic potential as 
compare to control.  
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The tissue sections of CIA injected control revealed the pathological changes 
that can be correlated with arthritis as compared to the normal control. In particular, 
marked hyperkeratosis of skin of footpad, infiltration of leukocytes and eosinophilic 
inflammatory exudates, edema in deeper subcutaneous tissues and proliferation of 
collageneous tissues was evident.  
The treatment with KVNC 200mg/kg showed marked reduction of the injury to 
tissue sections and most of the histological changes were minimized and found 
negligible as compared to the arthritis control. In particular, marked reduction in 
hyperkeratosis of skin of footpad, leukocytic and eosinophilic infiltration, edema and 
proliferation of collageneous tissues was evident. 
[83]
  
The most probable mechanism of this drug might be the inhibition of 
proinflammatory cells by KVNC which could have led to an alteration in the 
immunological milieu during the delayed phase of the response. 
The results obtained in the present study demonstrate beneficial effects of 
KVNC during recovery from arthritis by including Hb, ESR and body weight along 
with clinical signs histopathological examination. On the basis of the results obtained in 
the present study we suggest that possibly, the anti-arthritic potential of KVNC. May be 
through protection of synovial membrane, vascular permeability, prevention of cartilage 
destruction, thereby improving the health status. 
The results demonstrate the Anti-rheumatic effects of Keelvayu Nivarana 
Chooranam in the collagen induced arthritis in rats. The most probable mechanism of 
this drug might be the inhibition of proinflammatory cells by Keelvayu Nivarana 
Chooranam which could have led to an alteration in the immunological response. 
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      6. CONCLUSION 
The test drug Keelvayu Nivarana Chooranam was taken as a compound drug for 
Rheumatoid arthritis from the literature The Pharmacopoeia of Siddha Research 
Medicine (chapter 2-14) written by Dr. M. Shanmugavelu & Dr.G.D.Naidu, to validate 
the safety and its efficacy of drug to treating Analgesic, Anti-inflammatory, and Anti 
Rheumatic activity in animal model. 
The trial drug was subjected to various studies through which the efficacy of the 
drug is proved.  
The preparation of trial drug was standardized by physico chemical and bio 
chemical analysis. 
  The Physico chemical analysis the drug shows the presence of sulphur, calcium. 
phosphate. These elements are responsible for anti-rheumatic activity.  
FTIR analysis revealed the presence of O-H groups, C-C group, which indicates 
functional groups present in the sample. FTIR Interprets the moleculate structure of the 
sample. 
SEM analysis showed the size of the drug in micro particles which denotes that the 
trial drug could have potent drug delivery. 
  XRD analysis disclosed the percentage of elements presence in the drug. 
 The acute and sub-acute toxicological studies proved that the drug is nontoxic and 
safe.   
The pharmacological studies conducted by in vivo method revealed that the drug 
has effective Analgesic, Acute and Chronic Anti-Inflammatory, Anti-Rheumatic activity as 
well. The ESR values are also greatly reduced and moved towards normal. 
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7. SUMMARY 
The trial drug of “Keelvayu Nivarana Chooranam” has been selected and its 
efficacy was analyzed for the preclinical study to establish the analgesic, acute and chronic 
anti-inflammatory, anti-rheumatic activity. The drug is easily prepared and preparation is 
very simple when compared to modern drugs. The trial medicine is cost effective. It 
contains essential elemental, organic, constituents for its basic and potentiality and it 
represented the micro particles of its content.  
The ingredients of the test drug was identified and authenticated by Siddha experts. 
The drug was prepared as per the procedure and subjected to various studies to reveal its 
potency and effectiveness against the disease. 
 The phytochemical analysis reveals the presence of alkaloids, tannins, flavonoids, 
cardiac glycosides, saponins, phenols, proteins and carbohydrates. From the above analysis 
we came to know the presence of active ingredients responsible for its activity.  
Biochemical analysis showed the presence of Potassium, Calcium, Magnesium, 
Sodium and Iron. Thus from these results we come to know the effectiveness of the drug is 
due to the presence of these constituents and it has a synergistic effect in acting against the 
disease. 
The FTIR analysis construe the results that showed the presence of functional 
groups like alcohols, esters, alkanes, aromatic amines which might be responsible for the 
presence of anti-rheumatic action of the drug. SEM picture described its morphology and 
the particle size. 
Toxicological study of both acute and sub-acute toxicity study were carried out in 
animal model Wister albino rat according to the OECD guidelines. The toxicity helped to 
fix the doses as 1/5th and 1/10th for pharmacological activities that were carried out.  
The treated rats in the toxicity studies did not show any mortality, any untoward 
clinical sign, any behavioural signs, and alterations in body weight and necropsy findings at 
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the end of the study. This indicates that the dosages administered were below toxic level 
and proves the safety of the drug.  
Further acute and repeated 28 day oral toxicity studies were done to evaluate the 
safety of the drug. The mortality, functional observations, hematological and biochemical 
investigations were made. There was no significant change seen in the normal values.  
Thus the toxicological study of the test drug greatly establishes the safety and gives 
the justification for long time administration. 
The pharmacological study was carried out in the animal model Wistar albino rats. 
Three activities were seen in the drug Keelvayu Nivarana Chooranam. The activities were  
 
 Analgesic activity 
 Anti-inflammatory activity  
 Anti-rheumatic activity 
 
Analgesic activity was carried out in Acetic acid induced writhing test the test drug 
KVNC 100 mg/kg b.wt showed marked analgesic activity. Thus this activity reveals the 
effect of the drug against Rheumatoid arthritis. 
Anti-inflammatory of the trial drug Keelvayu Nivarana Chooranam was carried out. 
. This activity reveals the anti-inflammatory property of the test drug. 
Anti-rheumatic activity was carried out in collagen induced arthritis in Wistar 
albino rat models. The test drug showed significant decreases inflammation and decreased 
level of CRP in blood. Thus anti-rheumatic activity of the drug is justified. 
The anti-rheumatic activity of the drug Keelvayu Nivarana Chooranam is mainly of 
the presence of the active principles. The analgesic and the anti-inflammatory property of 
the test drug support the drug in treating RA.  
In RA is always accompanied with increased level of CRP. The drug showed 
significant decrease in the level of mentioned the entire above drug compared with than the 
standard drug. 
          Thus by scrutinizing all the above mentioned factors it is concluded that the test drug 
Keelvayu Nivarana Chooranam a safe and a potent anti-rheumatic drug.  
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To conclude, the drug Keelvayu Nivarana Chooranam beneficiary values for the 
therapeutic efficacy for anti-rheumatic activity. It also possesses analgesic, anti-
inflammatory activities which support the effective treatment for managing Rheumatoid 
arthritis. 
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8. FUTURE SCOPE 
The trial drug Keelvayu Nivarana Chooranam was taken from the literature 
The Pharmacopoeia of Siddha Research Medicine (chapter 2-14) written by Dr. M. 
Shanmugavelu & Dr.G.D.Naidu. Its validation for analgesic, anti-inflammatory and 
anti-rheumatic activity was completed at preclinical level. The result showed the 
assurance of Anti-Rheumatic activity against Rheumatoid Arthritis. Clinical trials are 
required to understand the exact molecular mechanism of action and it would be a safer 
drug for Rheumatoid Arthritis in worldwide. 
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                  Fig No.2. Ingredients of Keelvayu Nivarana Chooranam 
 
 
 
  
     PREPARATION OF KEELVAYU NIVARANA CHOORANAM 
 
                               
                 Pounding                         Sieving process 
 
 
 
                                           
                                Keelvayu Nivarana Chooranam 
 
 
                      Fig No. 3. Preparation of Keelvayu Nivarana Chooranam 
 
 
 
 
 
 
HISTOPATHOLOGY – 28 DAYS REPEATED ORAL TOXICITY STUDY 
 
            Control Group   Test Group (High Dose) 
 
          Kidney             Kidney 
                           
 
         Liver     Liver 
                                    
 
       Spleen      Spleen 
 
                        
 
Fig No.10.  Histopathology study of KVNC- Toxicity 
 
 
 
 
                  



